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ABSTRACT 
 
Fluorotelomer alcohols (FTOHs, F(CF2)nCH2CH2OH) are emerging 
contaminants in the environment.  Biodegradation of 6:2 and 8:2 FTOHs has been 
intensively studied using soils and activated sludge.  However, little is known about the 
bacteria responsible for biotransformation of FTOHs.  This study deciphered factors 
affecting biodefluorination of FTOHs and their metabolites, and developed three 
effective FTOH-degrading consortia. 
Two alkane-degrading Pseudomonas strains (P. oleovorans and P. butanovora) 
can defluorinate 4:2, 6:2 and 8:2 FTOHs, with a higher degree of defluorination for 4:2 
FTOH.  According to the identified metabolites, P. oleovorans transformed FTOHs via 
two pathways I and II.  Pathway I led to formation of x:2 ketone (x = n-1), x:2 sFTOH 
and perfluorinated carboxylic acids (PFCAs).  Pathway II resulted in the formation of 
x:3 polyfluorinated acid and relatively minor shorter-chain PFCAs.  Conversely, P. 
butanovora transformed FTOHs by pathway I only.  
Mycobacterium vaccae JOB5 (a C1-C22alkane-degrading bacterium) and P. 
fluorescens DSM 8341 (a fluoroacetate-degrading bacterium) can transform 6:2 FTOH 
via both pathways I and II with the formation of odd-numbered short-chain PFCAs.  In 
the presence of dicyclopropylketone or formate, P. oleovorans transformed 6:2 FTOH 
six times faster and produced odd-numbered PFCAs.  P. butanovora, utilized both 
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pathways I and II in the presence of lactate, and it also produced odd-numbered PFCAs.  
Unlike P. oleovorans, P. fluorescens DSM 8341 could slightly convert 5:3 
polyfluorinated acid (a key metabolite during 6:2 FTOH degradation, 
[F(CF2)5CH2CH2COOH]) to 4:3 acid and PFPeA via one-carbon removal pathways. 
Three FTOH-degrading consortia transformed FTOHs, with enhanced removal 
of FTOHs in the presence of n-octane.  A higher copy number of alkB gene was found 
to correspond to better removal of FTOHs, suggesting that alkane-degrading bacteria 
might be the key degraders in the enrichments.  The three enrichment cultures showed a 
similar microbial community structure. 
This is the first study reporting that pure strains of alkane- and fluoroacetate-
degrading bacteria can bio-transform FTOHs via different or preferred transformation 
pathways to remove multiple –CF2– groups from FTOHs to form shorter-chain PFCAs,  
and to other perfluorinated acids.  The results of this study also suggest that enhanced 
FTOH biodegradation is possible through co-substrate addition and/or using enrichment 
cultures. 
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1. INTRODUCTION AND OBJECTIVES 
 
1.1 Introduction 
 
Fluorotelomer alcohols [F(CF2)nCH2CH2OH]  (Table 1.1) are a group of 
fluorinated compounds with even-numbered fluorocarbon chains and an ethanol moiety.  
They are used as raw materials to manufacture surfactant and polymeric products [1].  
FTOH-based compounds have been used in a wide variety of products including paints, 
adhesives, waxes, polishes, metals, electronics, caulks, agrochemicals, blood substitutes, 
cookware coatings, refrigerants, fire-fighting foams, and lubricants [1].  From 2000 to 
2002, the production of FTOHs was estimated to be 5,000 tons/year in the world [2]. 
FTOHs have been detected in the troposphere at concentrations ranging from 7 to 196 
pg/m
3 
[3]or 11 to 165 pg/ m
3 
[4], with 6:2 and 8:2 FTOHs in majority. 
Abiotic and biotic transformation of FTOHs has been shown as one possible 
source for perfluorinated carboxylic acids (PFCAs, [F(CF2)mCOOH], 2 < m < 8) [2, 5, 6], 
which are persistent compounds that have been detected in the environment, wildlife, 
and humans [7-14].  The structures of perfluorinated compounds are shown in Table 
A1.1 in Appendix.  In 2003, the United States Environmental Protection Agency (U.S. 
EPA) requested comments on perfluorooctanoic acid (PFOA,F(CF2)7COOH), a PFCA of 
concern, due to its potential risks to human health and ecosystem [15].  In 2006, the 
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U.S. EPA invited eight major manufacturers of fluorinated compounds to participate on 
a 2010/2015 PFOA stewardship program to eliminate production and emission of these 
compounds by 2015 [16].  In response to the global PFOA stewardship program, the 
manufacturers have recently adopted 6:2 FTOH [F(CF2)6CH2CH2OH] as a raw material 
for the products of FTOH-based polymers [17, 18].  Therefore, new research is 
particularly needed to better understand the fate and transport of 6:2 FTOH in the 
environment.  
 
 
 
Table 1.1. Chemical structures of FTOHs 
Fluorotelomer alcohols (FTOHs) 
4:2 FTOH 
 
6:2 FTOH 
 
8:2 FTOH 
 
 
 
 
The carbon-fluorine bond is one of the strongest bonds in the nature, with up to 
130 kcal/mol of bond dissociation energy (BDE) [19].  For example, monofluorinated 
alkane (CH3-F) has 115 kcal/mol of BDE which is higher than other carbon-halogen or 
carbon-hydrogen bonds (104.9 kcal/mol for CH3-H, 83.7 kcal/mol for CH3-Cl, 72.1 
kcal/mol for CH3-Br, and, 57.6 kcal/mol for CH3-I) [20].  Due to the C-F bonds, poly- 
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and per- fluorinated chemicals such as FTOHs and PFCAs are stable at high temperature 
(up to 400 °C for PFCAs [21]), and resistant to chemical degradation, UV radiation, or 
weathering [22].  Therefore, FTOHs and the metabolites, PFCAs, are recalcitrant, 
accumulative and persistent in the environment [22, 23].   
However, recent studies have shown that FTOHs, particularly 8:2 FTOH (n=8), 
are subjected to abiotic degradation in atmosphere and biodegradation in soils and 
activated sludge [6, 17, 24,25].  Both FTOHs and their metabolites are known to have 
toxicological effects on laboratory animals and mammalian cell lines.  For instance, 6:2 
and 8:2 FTOHs exhibited estrogenic activity in the human breast MCF-7 cell line [26].  
In mammals, 8:2 FTOH degradation can also result in two transformation products 
production, PFOA and perfluorononanoic acid (PFNA), which can induce peroxisome 
proliferation in male mice [27], cause developmental toxicity in mouse neonates [28] 
and rats [29], and significantly increase mortality in pups [30].  PFNA has not yet been 
detected as a metabolite during biodegradation of 8:2 FTOH by bacteria [25, 31].  
Biodegradation of FTOHs has been observed in activated sludge [32], soils [33, 
34], and enrichment cultures with 8:2 FTOH [24] or 1,2-dichloroethane [5].  While 
biodegradation of FTOHs was once considered only possible on the ethanol moiety of 
FTOHs, the cleavage of C-F bond in 8:2 FTOH was first reported by Wang et al. [24].  
Numerous metabolites, including short-chain perfluorinated carboxylic acids (PFCAs, 
[F(CF2)mCOOH], m = 3, 4, or 5) and x:3 polyfluorinated acids ([F(CF2)xCH2CH2COOH], 
x = n-1, n = 6 or 8), have been detected [25].  Possible degradation pathways for 6:2 
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FTOH and 8:2 FTOH in aerobic soils have been proposed [17, 25].  Most recently, it 
was reported that 5:3 polyfluorinated acid ([F(CF2)5CH2CH2COOH]) (a metabolite of6:2 
FTOH degradation) could be transformed by activated sludge into 4:3 acid, 3:3 acid and 
short-chain PFCAs [35].  However, all of the previous studies were conducted in mixed 
cultures, providing little or no information about the microorganisms that are responsible 
for the FTOH biodegradation.  Furthermore, it is unknown which microorganisms can 
degrade FTOH metabolites, such as the short-chain PFCAs and/or x:3 polyfluorinated 
acids.  Such information is essential for assessing the fate and transport of FTOHs and 
their metabolites and their environmental impacts. 
Many aerobic alkane-degrading bacteria, express enzymes that activate diverse 
metabolic pathways and these microorganisms can utilize or degrade alkanes and other 
pollutants of different chain lengths [36-38].  Among these alkane-degraders, 
Pseudomonas butanovora and Pseudomonas oleovorans are two well-studied medium-
chain (C5-C12) alkane-degrading bacterial strains.  P. butanovora was isolated from 
activated sludge from an oil-refining company [39, 40] and expresses soluble butane 
monooxygenase (sBMO) that catalyzes the metabolism of C2-C9 n-alkanes and a number 
of primary alcohols [39].  P. oleovorans was isolated from soils by co-culturing with n-
hexane as a sole carbon source and the isolate can degrade n-octane to octanoic acid [41].  
P. oleovorans can utilize various substrates including C6 - C12 linear alkanes and alkenes 
in gas or liquid phase [42].  Another alkane-degrading bacterium, Mycobacterium 
vaccae JOB5 (Gram +), is capable of growing on 2-methylbutane [43] and expresses 
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diverse monooxygenases that metabolize a wide range of substrates (C1-C22) [43].  
Given that FTOHs are structurally similar to alkanes, it is possible that these alkane 
degraders may also degrade FTOHs. 
Decades of intensive research on dehalogenation, particularly on dechlorination, 
have identified and characterized numerous dehalogenases capable of breaking C-Cl 
bonds in aliphatic and/or aromatic compounds [44-55].  Some dehalogenases can 
defluorinate fluorinated compounds; however, only fluoroacetate dehalogenase is known 
to hydrolyze C-F bonds in aliphatics [56].  Fluoroacetate dehalogenase was first 
discovered in a Pseudomonas sp. isolated from river mud that is capable of using 
fluoroacetate as a sole carbon source [57].  Pseudomonas fluorescens DSM 8341 and 
Burkholderia sp. FA1 are two of the most studied fluoroacetate-degrading soil isolates.  
Among seven soil isolates ,P. fluorescens DSM 8341 was the most effective 
fluoroacetate-degrading bacterium [58] and the fluoroacetate dehalogenase expressed by 
these two strains have a much higher affinity for compounds with C-F bonds compared 
to those with C-Cl and C-Br bonds [56, 59].  Since PFCAs are structurally similar to 
fluoroacetate, it is possible that these fluoroacetate-utilizing strains can use fluoroacetate 
dehalogenase to defluorinate FTOHs. 
Enhanced biodegradation can be accomplished by enrichment cultures.  Using 
FTOHs or structurally similar compounds (eg. n-octane) as substrates for enrichment 
might increase effectiveness of FTOH-degrading microorganisms [5, 33].  Although 
previous studies have reported biodegradation of FTOH in enrichment cultures with 8:2 
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FTOH [24]or 1,2-dichloroethane [5], no systematic approach has been attempted to 
develop an enrichment culture system for enhanced FTOH biodegradation. 
Therefore, this study examined the biodegradation potential of FTOHs by 
several well-studied pure bacterial strains: including bacteria-that degrade alkanes (P. 
oleovorans, P. butanovora, and M. vaccae JOB5) and a bacterium containing 
fluoroacetate dehalogenase (P. fluorescens DSM 8341).  This is the first study attempt 
to examine the biodegradation of FTOHs (4:2, 6:2 and 8:2 FTOHs) and their known 
metabolites by these well-studied microorganisms.  Since it is expected that 6:2 FTOH 
will be widely used in the near future, this study also investigated the biodegradation of 
6:2 FTOH by the four strains (described above) under different co-substrate conditions.  
It was expected that addition of co-substrates might enhance the extent of defluorination 
during 6:2 FTOH degradation and/or result in decreased formation of short-chain PFCAs 
as end-products.  Additional research efforts were focused on development of a mixed 
culture capable of defluorinating FTOHs to environmental friendly end-products.  The 
performance of these FTOH-degrading enrichment cultures were linked to their unique 
microbial community structures and the quantity of alkB genes, a presumptive catabolic 
gene for FTOH degradation.  
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1.2 Goals, objective and hypothesis 
 
The goal of this study was to decipher factors affecting biodefluorination of 
FTOHs and their metabolites, and to develop enhanced biological treatment strategies 
for removal of FTOHs.  To achieve this goal, four specific objectives were identified 
and accomplished and a description of these objectives, and associated hypotheses and 
tasks is outlined below.   
 
Objective 1: Examine biodegradation potential of FTOHs by medium-chain alkane-
degrading bacteria  
Hypothesis: Due to structural similarities between FTOHs and medium-chain 
alkanes and their broad substrate range, we hypothesize that medium-chain 
alkane-degrading bacteria can degrade FTOHs.    
Task 1a: Examine degradability of FTOHs by two well-studied 
medium-chain alkane degrading bacteria, P. oleovorans and P. 
butanovora 
Task 1b: Identify transformation metabolites of FTOHs and possible 
FTOH degradation pathways by those two strains. 
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Objective 2: Examine biodegradation potential of 6:2 FTOH by C1-C22 alkane- and 
fluoroacetate-degrading strains 
Hypothesis: We hypothesize that 6:2 FTOH can be degraded by alkane- and 
fluoroacetate-degrading bacteria.  
Task 2a: Examine the biodegradation of 6:2 FTOH by M. vaccae JOB5, 
a C1-C22 alkane-degrading bacterium. 
Task 2b: Examine biodegradation of 6:2 FTOH by P. fluorescens DSM 
8341, a fluoroacetate-degrading bacterium 
 
Objective 3: Examine the effects of co-substrates on biodegradation of 6:2 FTOH  
Hypothesis: We hypothesize that the addition of co-substrates will induce 
expression of different enzymes or provide needed reducing energy to enhance 
6:2 FTOH biodegradation.  The enhanced degradation can be evaluated with 
respect to the extent of defluorination or the ability to degrade key metabolites, 
such as short-chain perfluorinated carboxylic acids (PFCAs) or x:3 
polyfluorinated acids, to less concerned products. 
Task 3a: Examine the effects of co-substrates on the extent of 
defluorination of 6:2 FTOH by alkane- and fluoroacetate-degrading 
bacteria. 
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Task 3b: Examine biodegradation of short-chain PFCAs by P. 
oleovorans and P. fluorescens DSM 8341 in the presence of co-
substrates 
Task 3c: Examine biodegradation of 5:3 polyfluorinated acid by P. 
oleovorans and P. fluorescens DSM 8341 in the presence of co-
substrates 
 
Objective 4: Develop and characterize FTOH-degrading microbial consortia  
Hypothesis: We hypothesize that alkanes are ideal co-substrates for enriching 
effective FTOH-degrading consortia. 
Task 4a: Develop FTOH-enrichment microbial consortia using activated 
sludge from a wastewater treatment plant (WWTP) treating 
perfluorinated-compound-containing wastewater from a fire-fighting 
training field.  Use 8:2 FTOH and/or one of the co-substrates (n-octane 
or 1-butanol) for enrichment.  
Task 4b: Examine the degradation ability of FTOHs by the enrichment 
cultures.  Link the degradation performance to presumptive catabolic 
gene (alkB gene) and associated microbial community structure. 
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1.3 Dissertation overview 
 
This dissertation consists of six chapters.  Chapter 1 described the problems 
regarding the occurrence of FTOHs in the environment as well as the goal and objectives 
of this research.  In Chapter 2, current literature on FTOHs, potential FTOH-degrading 
bacteria and molecular tools for microbial community analysis are summarized.  The 
knowledge gaps and research needs in biodegradation of FTOHs are also identified.  
The results of task 1a and 1b are described in Chapter 3.  The biodegradation of 
FTOHs by two pure alkane-degrading bacteria (P. oleovorans and P. butanovora) was 
examined.  The extent and the amount of FTOH biodefluorination by these strains were 
identified.  The recovery of free fluoride ions at the end of the degradation indicates the 
occurrence of defluorination of FTOHs.  This was the first study attempting to examine 
biodegradation of FTOHs by these well-studied microorganisms.  Materials presented 
in Chapter 3 have been published in Biotechnology and Bioengineering [31] and 
modified to the dissertation format with copyright permission from Wiley Periodicals, 
Inc., A Wiley Company.  Results of the tasks in Objective 2 and 3 are summarized in 
Chapter 4.  Specifically, biodegradation of 6:2 FTOH by M. vaccae JOB5 (a C1-
C22alkane-degrading bacterium) and P. fluorescens DSM 8341 (a fluoroacetate-
degrading bacterium) was observed, indicating that bacteria other than the two alkane-
degrader strains (P. oleovorans and P. butanovora) can also degrade FTOH.  In 
addition, the effects of various co-substrates on the types of transformation products and 
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extent of defluorination of 6:2 FTOH was investigated.  Among the tested strains, P. 
fluorescens DSM 8341 was the only strain capable of degrading a selected metabolite, 
5:3 perfluorinated acid.  In Chapter 5, the effects of co-substrates on FTOH 
degradation by enriched mixed cultures are described.  Meanwhile, the microbial 
community changes in mixed cultures during degradation of FTOHs were analyzed by 
molecular methods.  In Chapter 6, the findings of this study are summarized, and the 
implications of the results of this work and future research directions are also discussed.  
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2. LITERATURE REVIEW 
 
2.1 Fluorotelomer alcohols (FTOHs)  
 
2.1.1 Chemical and physical properties of FTOHs  
 
FTOHs are produced through a telomerization process with even-numbered 
fluoroalkyl chains and an ethanol moiety.  The telomerization developed by DuPont is 
defined as a process of reacting a molecule, called telogen, with two or more 
ethylenically unsaturated molecules, called taxogens [YZ (telogen) + nA (taxogen) → 
Y−(A)n−Z (telomere)].  The chemical formula of FTOHs can be expressed as 
F(CF2)nCH2CH2OH, where n is the number of fluoralkyl chains.  Based on the number 
of the fluoralkyl chains (n) and the non-fluorinated carbons (i.e., 2), FTOHs are 
commonly referred as n:2 FTOHs.  For example, 8:2, 6:2, and 4:2 FTOH represent 
[F(CF2)8CH2CH2OH], [F(CF2)6CH2CH2OH], and [F(CF2)4CH2CH2OH], respectively.  
Due to the fluoralkyl chains and ethanol moiety in FTOHs, FTOHs provide unique 
surface modification properties such as water and oil repellency in polymeric products 
and wetting and leveling in surfactants [1].  FTOHs are volatile and only slightly 
soluble in water (140 µg/L for 8:2 FTOH, [60]).  The estimated dimensionless Henry’s 
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law constant for 8:2 FTOH is 270 [23].  In water, FTOHs quickly evaporate from the 
surface [24] and due to the strong C-F bonds, FTOHs are resistant to chemical 
degradation, UV radiation, or weathering, making them persistent in the environment 
[22].   
 
2.1.2 Sources and fate of FTOHs in the environments 
 
FTOHs have been detected in wastewater effluent [61] and sludge applied soils 
[62, 63] and the transformation products such as PFCAs are frequently found in the 
environment, wildlife, and human [7-14].  However, the origin and environmental fate 
of FTOHs and their transformation products, particularly PFCAs, are still largely 
unknown.  One potential source could be the residual FTOHs from FTOH-based 
polymers, and/or the breakage of the covalent bonds of FTOH-based polymers at 
industrial production facilities,  and recent study reported that aqueous solutions of 
FTOH-based products are released from production facilities into wastewater, and the 
products may undergo biodegradation in wastewater treatment facilities, landfill or other 
environments [24].  FTOHs and their metabolites tend to adsorb rapidly into soils and 
sludge and the sorption is irreversible [24].  Biotic and/or abiotic degradation of 
polymer and nonpolymeric materials containing FTOHs has been suggested as a source 
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of atmospheric contamination [2] and this statement is supported by the detection of high 
concentrations of perfluorinated compounds in the urban troposphere [3, 4].  
 
2.1.3 Toxicity  
 
6:2 and 8:2 FTOHs exhibited estrogenic activity and enhanced proliferation in 
an in vitro assay using MCF-7 human breast cancer cells [26].  Comparing to the 
reference compound 17β-estradiol (E2), these FTOHs also induced the expression of 
estrogen-responsive genes.  Exposure of MCF-7 cells to 6:2 and 8:2 FTOH 
significantly increased the number of cells in the synthesis phase (S-phase) of the cell 
cycle and stimulated synthesis of new DNA required for cell division (i.e. the increase of 
cancer cells).  Interestingly, other perfluorinated compounds – perfluoro-1-octane 
sulfonate (PFOS), PFOA and PFNA– did not exhibit estrogenic activity.  These results 
are different from other studies reporting that exposure to PFOA and PFNA (known as 
8:2 FTOH metabolites)caused peroxisome proliferation, development toxicity and 
mortality to animals and mammalian cell lines [27-30]. 
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2.1.4 Abiotic degradation of FTOHs 
  
Ellis et al. [2] showed FTOHs can react with Cl atoms and OH radicals in the air 
and the reaction rate was not affected by the chain length of FTOHs.  However, the 
fluorinated carbons seemed to deactivate the reaction between –CH2- groups and Cl 
atoms or OH radicals, compared to that observed for non-fluorinated alcohols (like 
ethanol) or glycerol.   
Possible pathways for abiotic degradation of FTOHs in the air were proposed by 
Ellis et al. [6].  During the abiotic degradation, FTOHs first interact with OH radicals 
and oxygen, followed by a series of reactions to produce PFCAs (Fig. 2.1). The 
production of OH radicals in the air is associated with the formation of H2O in molecular 
clouds.  The molecular cloud is a cool dense interstellar region composed primarily of 
hydrogen and a wide variety of molecules.  In the cold environment, the hydronium ion 
(H3O
+
) is formed from H2O via proton transfer reactions and is then converted into 
hydrogen and OH radicals by dissociative recombination (O + H3
+
 → H2 + OH
+
) [64, 
65]. 
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2.1.5 Biotic degradation of FTOHs 
  
It was once considered that only the ethanol moiety, not the C-F bonds, of 
FTOHs can be biodegraded.  In 2005,Wang et al. [24] reported the first evidence for 
cleavage of C-F bonds in 8:2 FTOH in activated sludge.  In a later study, the possible 
degradation pathways for 8:2 FTOH in aerobic soils was proposed [25].  According to 
the proposed pathways (Fig. 2.2), 8:2 FTOH is first transformed into 8:2 FTCA (8:2 
fluorotelomer acid) which can be catalyzed by alcohol and aldehyde dehydrogenase, and 
then to 8:2 FTUCA (8:2 fluorotelomer unsaturated acid) via multiple steps, including HF 
elimination.  8:2 FTUCA is a direct precursor of 7:2 sFTOH, which is then converted to 
PFOA.  It was suggested that the conversion of 7:2 sFTOH to PFOA is catalyzed by 
monooxygenases.  In addition, 7:2 sFTOH can be transformed into the 7:2 ketone and 
to 2H-PFOA via multiple enzymatic reactions.  Through reductive defluorination, 8:2 
FTUCA can also be degraded to 7:3 Uacid.  7:3 Uacid is further transformed to α-OH 
7:3 acid and to 7:3 acid in which a dehydrogenase might be involved, or to PFHxA 
(perfluorohexanoic acid ) possibly via allylic isomerases and hydrogenases [25].  The 
enzymes involved in each step of 8:2 FTOH of the proposed degradation pathways have 
not been confirmed or identified. 
With an increasing concern over the large usage of 8:2 FTOH and its 
transformation products (particularly PFOA), there has been a move to replace 8:2 
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FTOH with 6:2 FTOH (a shorter FTOH) as a raw manufacture material.  Thus, new 
studies have been initiated to examine the biodegradation potential of 6:2 FTOH in the 
environment.  Similar to 8:2 FTOH biodegradation, 6:2 FTOH was degraded in aerobic 
soils and mixed bacterial cultures developed from activated sludge previously exposed to 
fluorinated compounds [17], but with a more rapid rate [17, 25].  Many transformation 
metabolites were detected during 6:2 FTOH biodegradation by soils and the enrichment 
culture [17].  These common metabolites reported in this study were 6:2 FTCA, 6:2 
FTUCA, 5:2 ketone, 5:2 sFTOH, α-OH 5:3 acid, 5:3 Uacid, PFBA (perfluorobutanoic 
acid), PFPeA (perfluoropentanoic acid), PFHxA and 5:3 acid.  However, 4:3 acid was 
detected only in aerobic soil, and 5:3 ketone aldehyde [F(CF2)5COCH2CHO] and 5:3 
Uamide were detected only in the enrichment culture.  Interestingly, 5:3 ketone 
aldehyde and PFPeA were detected during 6:2 FTOH degradation while 7:3 ketone 
aldehyde and PFHpA (the analogous metabolites) were not detected during 8:2 FTOH 
degradation, suggesting that (i) 6:2 FTOH is more biodegradable and (ii) new 
degradation pathways for 6:2 FTOH might be present [17, 25].  6:2 FTOH degradation 
pathways were proposed as illustrated in Fig. 2.3 [17].  To further examine the potential 
for degrading 5:3 polyfluorinated acid in soils and activated sludge, Wang et al. [35] 
discovered a new degradation pathways, called the ―one-carbon removal pathways‖ [35].  
Through these pathways, 5:3 polyfluorinated acid was transformed to α-OH 5:3 acid 
[F(CF2)5CH2CH(OH)COOH] as the dominant metabolite, followed by 5:2 acid 
[F(CF2)5CH2COOH], 5:3 Uacid [F(CF2)5CHCHCOOH], 5:2 Uacid 
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[F(CF2)4CFCHCOOH], and several minor metabolites (PFPeA, PFBA [perfluorobutyric 
acid, F(CF2)3COOH], 4:3 acid [F(CF2)4CH2CH2COOH] and 3:3 acid 
[F(CF2)3CH2CH2COOH])[35].  These degradation pathways result in a production of 
mixtures of x:3 acid (x<5), α-OH x:3 acid (x = 4 or 5), and short-chain PFCAs (m = 3 
and 4).  These metabolic pathways are favorable; however, little is known about 
microorganisms and enzymes responsible for mechanism of these reactions.  
Identifying pure bacterial strains capable of degrading 5:3 acid via one-carbon removal 
pathways will provide valuable information for creating favorable environmental and 
physiological conditions for enhanced degradation of 6:2 FTOH, i.e., beyond 5:3 acid 
and/or short-chain PFCAs.  
 
2.2 Potential FTOH-degrading bacteria: alkane- and fluoroacetate-degrading bacteria 
 
The chemical structure of FTOHs is very similar to n-alkanes.  Since many 
alkane-degrading bacteria can utilize alkanes with different chain length and also 
cometabolize a range of aliphatic compounds, it was hypothesized thatalkane-degrading 
bacteria might be able to degrade FTOHs, either metabolically or cometabolically, into 
shorter and less-fluorinated metabolites and/or less harmful end-products.   
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Fig. 2.1.OH-initiated oxidation pathways for telomer alcohols [6]
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Fig. 2.2. Proposed biodegradation pathways of 
14
C-labeled 8:2 FTOH [25]
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Fig. 2.3. Proposed biodegradation pathways of 6:2 FTOH: The product in brackets is the proposed intermediate and those in 
boxes are terminal metabolites [17]. 
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To test this hypothesis, three well-studied alkane-degrading bacteria (P. 
oleovorans, P. butanovora, and M. vaccae JOB5) were selected since these strains are 
known for their ability to grow on alkanes and to co-metabolize many environmentally 
persistent pollutants [42, 66-72]. 
Bacteria, capable of expressing fluoroacetate dehalogenase to cleavage C-F 
bonds in fluorinated aliphatic compounds, were also selected for this study since 
fluoroacetate-dehalogenase-expressing bacteria might be able to transform FTOHs into 
less recalcitrant products.  Pseudomonas fluorescens DSM 8341 and Burkholderia sp. 
FA1 are two well-studied bacteria expressing fluoroacetate dehalogenases that exhibit a 
strong affinity toward a C-F bond, but a poor affinity toward chloroacetate and 
bromoacetate [56, 59].  Below is a brief review on each of these potential FTOH-
degrading bacteria.  
 
2.2.1 Alkane-degrading bacteria 
 
Aliphatic hydrocarbons, including n-alkanes, branched alkanes and alkenes, are 
ubiquitous in the environment [73].  Many alkane-degrading bacteria contain special 
enzymes, allowing them to utilize or degrade alkanes with different chain lengths and 
other pollutants [36-38].  Most of microorganisms initiate the oxidation of n-alkanes by 
hydroxylase (monooxygenase) system [73] and AlkB is one of the key alkane 
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hydroxylases [38].  In this study, three well-studied alkane-degrading strains, P. 
oleovorans, P. butanovora and M. vaccae JOB5, were used as model strains to explore 
their ability to degrade FTOHs and background and information on these strains is given 
below. 
 
2.2.1.1 Pseudomonas oleovorans 
 
P. oleovorans was isolated from soils in 1963 [41] and this strain can grow on n-
hexane as a sole carbon source and degrade n-octane to octanoic acid [41].  P. 
oleovorans can oxidize alkanes because it contains an OCT plasmid, encoding a 
complex of monooxygenases.  The OCT plasmid consists of two regions: the alkBAC 
operon (= alkBFGHJKL operon) and the alkR regulatory region.  The alkBAC operon 
encodes alkane hydroxylase (a three component monooxygenase adding one oxygen 
atom to a substrate), alkanol dehydrogenases and aldehyde dehydrogenases.The 
expression of alkB genes on the OCT plasmid can be gratuitously induced by 
dicyclopropylketone (DCPK) [74, 75].  Using these enzymes, P. oleovorans can also 
oxidize alkanes to alkanols, alkanals and alkanoic acids.  This strain has a broad 
substrate range, including C6 to C12 linear alkanes, or alkenes in gas or bulk liquid 
phase[42].  P. oleovoransalso degrades crude oil [38], chlorinated compounds [76] and 
methyl tertiary butyl ether (MTBE) in the presence of DCPK [77]. 
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2.2.1.2 Pseudomonas butanovora 
 
P. butanovora is a gram-negative, rod-shaped, aerobic bacterium which was 
originally isolated from activated sludge from an oil-refining company [39, 40].  
Soluble butane monooxygeanse (sBMO) expressed by this strain initiates the oxidation 
of butane to 1-butanol [68].  1-Butanol is then transformed by two alcohol 
dehydrogenases to butyraldehyde which is further degraded to butyrate [78].  Both 
butane and 1-butanol are inducers for sBMO; however, it was reported that 1-butanol 
was a more efficient inducer of sBMO in this strain [79].  P. butanovora can grow on 
C2-C9 n-alkanes and a number of primary alcohols [39] and this strain can also degrade 
different chlorinated alkanes and aromatics [67, 71, 72]. 
 
2.2.1.3 Mycobacterium vaccae JOB5   
 
M. vaccae JOB5, isolated from soil, is a gram-positive bacterium.  The strain 
was isolated for its ability to use isopentane (2-methylbutane) as a sole carbon and 
energy source [43].  The strain can also grow on a wide range of substrates (C1-C22) [43] 
and expresses diverse enzymes including butane monooxygenase (BMO) [80], propane 
monooxygenase (PMO) [81], and AlkB (alkane hydroxylase) [82] in response to its 
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growth conditions.  Propane-grown M. vaccae JOB5 are known to degrade 
trichloroethylene [66], BTEX (benzene, toluene, ethylbenzene, and xylenes) [83], 
tertiary butyl alcohol (TBA) [82], and 1,4-dioxine [84].  Butane-grown M. vaccae 
JOB5 can degrade chloroform [67], and n-octane-grown M. vaccae JOB5 can degrade 
methyl tertiary butyl ether (MTBE) [85]. 
 
2.2.2 Fluoroacetate-degrading bacteria 
 
Fluoroacetate [F(CH2)COOH] is a fluorinated compound that is naturally 
produced by some plants and a bacterium (Streptomyces cattleya).  Although 
fluoroacetate is not toxic to plants and bacteria, it is highly toxic to mammals [86, 87].  
Among various known dehalogenases [47, 88-95], fluoroacetate dehalogenase, 
expressed by fluoroacetate-degrading bacteria, is the only enzyme capable of 
hydrolyzing the C-F bond of fluoroacetate [56].  
Since the first report of bacterial defluorination of fluoroacetate by Goldman[57], 
several fluoroacetate-degrading microorganisms such as Moraxella, Pseudomonas, and 
Burkholderiahave been isolated [56, 96].  The fluoroacetate dehalogenases expressed 
by Moraxella sp. B and Burkholderia sp. FA1 can defluorinate fluoroacetate via a two-
step mechanism similar to that catalyzed by haloalkane dehalogenase.  In the first step, 
the aspartate residue at the active site of the enzyme attacks the α-carbon atom 
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nucleophilically.  This attack causes the release of the fluoride ion and formation of the 
ester intermediate.  In the second step, the intermediate is then hydrolyzed by a water 
molecule to produce glycolate.  Figure 2.4 shows the defluorination of fluoroacetate 
dehalogenase (FAc-DEX H1) from Moraxella sp. B [96, 97].  
Sodium monofluoroacetate(SFA), consisting of a carboxylic group and a C-F 
bond, is structurally very similar to a short-chain PFCA.  Recent studies [17, 25] have 
reported that short-chain PFCAs appear to be the accumulative products during 
degradation of FTOHs.  Accordingly, these fluoroacetate-dehalogenase-expressing 
strains might be able to degrade short-chain PFCAs into diverse transformation 
metabolites as reported during biodegradation of FTOHs by activated sludge and soils 
[25].  Thus, this study examined the biodegradation potential of short-chain PFCAs by 
fluoracetate-degrading bacteria.  In addition, the biodegradation potential of x:3 acids 
by fluoracetate-degrading bacteria were investigated. 
 
Fig. 2.4. The reaction of defluorination by fluoroacetate dehalogenase, FAc-DEX H1 [59] 
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2.2.2.1 Pseudomonas fluorescens DSM 8341 
 
Pseudomonas fluorescens DSM 8341, one of seven isolates from western 
Australian soils, is the most efficient strain in defluorinating SFA[58].  The 
fluoroacetate dehalogenase, expressed by P. fluorescensDSM 8341, can also 
dehaolgenate other halogenated compounds (chloroacetate and bromoacetate) but less 
efficiently.  The enzyme also has a poor substrate specificity toward ethyl fluroacetate 
and was unable to degrade fluroacetamide, suggesting that the carboxyl group in 
halogenated compounds might play an important role in substrate affinity.  It was also 
reported that the presence of Mg
2+
 increased the enzyme activity by 20-25% [59].  
 
2.2.2.2 Burkholderia sp. FA1  
 
Burkholderiasp. FA1 is also a soil fluoroacetate-utilizing bacterium.  The 
dehalogenase expressed by this strain, called FAc-DEX FA1, was specific to haloacetate, 
particularly fluoroacetate.  FAc-DEX FA1 was only induced in the presence of 
fluoroacetate.  The enzymatic structure of FAc-DEX FA1 was similar to that of FAc-
DEX H1 from Moraxellasp. B [56]. 
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2.3 Molecular techniques used to characterize FTOH-degrading consortia 
 
Most of our knowledge of biodegradation of target compounds has been 
obtained from laboratory studies of bacterial isolates [98, 99].  However, more than 99% 
of bacteria are not cultivable in a laboratory setting [100] and results obtained from the 
isolates are biased and might not be relevant to what occurs in the environment.   
In this study, FTOH-degrading consortia were developed and characterized by 
two specific culture-independent methods.  These two methods are real-time terminal 
restriction fragment length polymorphism (real-time t-RFLP) which has been 
successfully used to monitor diverse microorganisms in the environment [101-103] and 
real-time PCR which can be used to quantify the strains and/or catabolic genes [102, 
104].  These two methods are briefly described below.  
 
2.3.1 Detection of catabolic genes by real-time PCR 
 
Real-time PCR is a fluorescence-based kinetic PCR method for quantifying the 
initial number of copies of a target gene [105].  In the first step in real-time PCR, a 
fluorescence-labeled probe is complementarily bound to the target DNA or nucleic 
acid stain such as SYBR Green is bound to any existing double stranded DNA in the 
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sample.  During the amplification, the fluorescent label is cleaved and the released 
fluorescent signals are recorded at the end of each PCR cycle.  The detected signals are 
then compared to a set of standard curves for quantification [106].   
AlkB (alkane hydroxylase) is known as one of key enzymes for alkane 
degradation and the alkB gene has been most commonly used for detection of alkane-
degrading bacteria in the environment [107].  From the previous study on degradation 
of FTOHs by alkane-degrading bacteria [31], we hypothesized alkB gene coding alkane 
hydroxylase might be one of responsible genes for degradation of FTOHs.  Based on 
former studies for primers design [108-110], forward and reverse primers were chosen to 
detect microorganisms containing the alkB gene in FTOHs degrading consortia and to 
investigate the effects of this bacterial group on FTOH degradation in the natural 
environment. 
 
2.3.2 Characterization of FTOH-degrading microbial community using Real-time 
terminal restriction fragment length polymorphism (real-time-t-RFLP) assay 
 
A quantitative fingerprinting method, called the real-time terminal restriction 
fragment length polymorphism (real-time-t-RFLP) assay, has been successfully used to 
study the microbial community structures in activated sludge, microcosms, and 
enrichment cultures [101-103].  Real-time-t-RFLP assay, integrating real-time PCR and 
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t-RFLP, is a quantitative finger printing assay [102]. Briefly, the 16S rRNAs in 
templates are PCR amplified using fluorescent-labeled primers and probes, and the 
amplified PCR products are digested with a restriction enzyme.  The digested PCR 
products generate various fluorescence-labeled terminal restriction fragments (T-RF).  
The microbial community profile is characterized as a series of T-RF peaks, representing 
different phylotypes in a microbial community.  The fluorescence intensity of the peaks 
reflects the relative abundance of each phylotype [111].  The signals are then compared 
to a set of standard curves for quantification of the target gene[102, 106].  The gene 
copy number for a T-RF can be calculated by multiplying the area of the T-RF portion 
and the total gene copy number in the sample.  
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3. BIOTRANFORMATION OF FTOHS BY TWO PURE ALKANE-
DEGRADING BACTERIA: P. oleovorans AND P. butanovora* 
 
3.1 Introduction 
 
Perfluorinated carboxylic acids (PFCAs) and perfluorinated sulfonic acids are 
persistent compounds that have been detected in the environment, wildlife, and humans 
[7-14].  The environmental sources of PFCAs are not fully understood; however, one 
possible source of PFCAs comes from abiotic and biotic transformation of fluorotelomer 
alcohols (FTOHs) and their precursors [2, 5,6] 
FTOHs [F(CF2)nCH2CH2OH], consisting of a hydro- and oleo- phobic 
perfluoroalkyl moiety and an ethanol moiety, are used as raw-materials to manufacture 
surfactants and polymeric products with water- and oil-repelling properties [1].  The 
unique properties of FTOH-based products have led to a wide variety of applications 
including paints, adhesives, waxes, polishes, metals, electronics, caulks, agrochemicals,  
 
* Reprinted with permission from ―Biodefluorination and Biotransformation of 
Fluorotelomer Alcohols by Two Alkane-Degrading Pseudomonas Strains‖ by Myung 
Hee Kim, Ning Wang, Thomas McDonald, Kung-Hui Chu, 2012, Biotechnology and 
Bioengineering, Online available, Copyright [2012] by Wiley Periodicals, Inc., A Wiley 
Company. 
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refrigerants, fire-fighting foams, and lubricants [1].  From 2000 to 2002, the production 
of FTOH-based products was estimated to be ~6000 tons of fluorotelomer A 
equivalents/year worldwide [112].  
FTOHs are volatile and relatively water insoluble (carbon chain-length 
dependent) in the absence of a sorbing medium [113], and they have a tendency to be 
adsorbed strongly to solid matrices such as household dusts [114], soils and activated 
sludge [24, 113, 115].  Field monitoring studies report detection of FTOHs in the 
troposphere at concentrations ranging from 7 to 196 pg/m
3 
[3] and averaged 87 pg/ m
3 
[116] with 6:2 and 8:2 FTOHs being the major components.  The major source of 
environmental FTOHs is postulated to be the residual unreacted FTOH present in 
commercial products [2].  A recent study suggests that the current practice of applying 
sludge from WWTPs to soils is a potential pathway to introduce FTOHs and PFCAs to 
the environment [63].   
Similar to the historical aspect of PCB dechlorination [117], microbial removal 
of –CF2– groups from FTOHs is considered extremely difficult due to the strength of C-
F bonds in the perfluoroalkyl moiety of FTOHs.  Early studies report biotransformation 
of 8:2 FTOH in 1,2-dichloroethane enrichment culture [5], activated sludge [24], and 
soils [25, 33].  By using 
14
C-labeled 8:2 FTOH, Wang et al. [24] reported the first 
evidence of C-F bond cleavage in 8:2 FTOH by activated sludge.  In recent years, Liu 
et al. [17] and Wang et al. [25] reported more FTOH transformation products from 
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FTOH defluorination and proposed possible transformation pathways for 6:2 FTOH and 
8:2 FTOH in aerobic soils.  All these findings were derived from experiments with 
mixed cultures or microbial consortia, providing little or no knowledge about the 
specific microorganisms that are responsible for the FTOH biotransformation.  
Furthermore, it is unclear which transformation pathways are preferred or used by the 
degradative microorganisms under the study conditions.   
Many alkane-degrading microorganisms are known for their degradative 
enzymes and diverse metabolic pathways, enabling them to utilize or degrade alkanes 
and other pollutants with different chain lengths [36-38].  Among these alkane-
degraders Pseudomonas butanovora and Pseudomonas oleovorans are two well-studied 
middle-chain (C6-C12) alkane-degrading strains.  P. butanovora is a butane-oxidizing 
bacterium originally isolated from the activated sludge of oil-refining waste [39, 40].  
In addition to butane, P butanovora can grow on C2-C9 n-alkanes and a number of 
primary alcohols [39].  This strain expresses soluble butane monooxygenase (sBMO) to 
oxidize butane to 1-butanol [68], which is further converted to butyraldehyde, and then 
to butyrate [78].  Previous studies also showed that sBMO can degrade a wide range of 
chlorinated alkanes and aromatics via cometabolic reactions [67, 71,72].  P. oleovorans 
is a soil isolate known for its ability to express alkane monooxygenases to degrade n-
octane to octanoic acid [41] and to oxidize various C6 to C12 linear alkanes or alkenes 
[42].  Both sBMO and alkane monooxygenase have a broad substrate specificity.  
Given that FTOHs are structurally similar to middle-chain alkanes, it is possible that 
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these two middle-chain alkane-degrading strains can use the enzymes expressed for 
alkane oxidation to transform FTOHs.   
In this study, we examined the biodegradability of FTOHs (4:2, 6:2 and 
8:2FTOHs) by the aforementioned two Pseudomonas strains.  This is the first report to 
show that individual pure bacterial strains were able to defluorinate FTOHs to form 
transformation products with shorter chain lengths, resulting in the removal of three –
CF2– groups from FTOHs.  Furthermore, this work demonstrated that the two 
individual microbial strains deployed different pathways to transform FTOHs.  
 
3.2 Materials and methods 
 
3.2.1 Chemicals 
 
1H, 1H, 2H, 2H-heptadecafluoro-n-decanol (8:2 FTOH, CAS # 678-39-7, >96 % 
pure) was purchased from TCI America (manufactured in Tokyo, Japan).  1H, 1H, 2H, 
2H-perfluorooctanol (6:2 FTOH, CAS # 647-42-7, 97 % pure) was obtained from Alfa 
Aesar (Lancashire, UK). 1H, 1H, 2H, 2H-perfluorohexan-1-ol (4:2 FTOH, CAS # 2043-
47:2) was purchased from Aldrich Japan. Hexane (95 % pure) was obtained from Acros 
Organics (UK).  1-Butanol (99.4 % pure) was purchased from Fisher Scientific (Fair 
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Lawn, NJ) and n-octane (97 % pure) was from Acros Organics (Geel, Belgium).  
Acetonitrile (> 99% pure) was purchased from Acros Organics (Geel, Belgium), and 
ethanol (95% purse) was from IBI scientific (Peosta, IA).  The experiments were 
conducted in two parts: 1) 4:2 FTOH transformation test using GC-MS and GC-ECD, 
and 2) 6:2 and 8:2 FTOH transformation and metabolites identification using 
LC/MS/MS.  For the 4:2 FTOH transformation test, the pure compound (in liquid form) 
was used directly.  For LC/MS/MS analysis to quantify FTOH and potential 
metabolites, 8:2 and 6:2 FTOHs were prepared in 50% ethanol (ethanol:water = 1:1) as a 
stock solution to be dosed into individual bacterial culture samples.   
For LC/MS/MS analysis, perfluorinated carboxylic acid standards were 
purchased from either Sigma-Aldrich (St. Louis, MO) or Synquest Laboratories 
(Alachua, FL); 6:2 FTOH was from Fluka (St. Louis, MO); and 5:2 and 7:2 ketones 
were from TCI America (Portland, OR).  [M+5] PFHxA, the internal standard, was 
from Wellington Laboratories (Guelph, Ontario, Canada).  The rest of the 
polyfluorinated acid standards used for quantitative analysis were synthesized by 
DuPont (Wilmington, DE).  All standards used have a purity of +97%. 
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3.2.2 Bacterial strains and growth conditions 
 
The P. oleovorans was purchased from America Type Culture Collection 
(ATCC number # 29347).  The P. oleovorans was grown in P1 medium [118] with 1% 
n-octane to an optical density at 660 nm (OD660) of 1.0 before being harvested for 
experimental use.  The cells were centrifuged at 10,000 g for 5min, washed twice with 
0.1 M phosphate buffer (pH = 7), and the pellet was then resuspended in P1 medium 
(100 mL for the short-term experiments and 250 mL for the long-term experiments) for 
experimental use.  The P. butanovora was generously provided by Dr. Daniel J. Arp, of 
Oregon State University.  The cell suspension was prepared similarly as described 
above, except that P. butanovora was pregrown in ATCC1581 medium [68] with 2 mM 
1-butanol to OD600= 0.5-0.7. 
 
3.2.3 Short-term experiments for FTOH transformation 
 
Transformation experiments with 4:2 FTOH were conducted in a series of 22 
mL-glass vials containing 5 mL of P. oleovorans (or P. butanovora) cell suspension 
dosed with 4:2 FTOH.  The vials were first sealed with PTFE-faced silicone rubber 
septa and caps before adding 4:2 FTOH by using a 25 μL-gas tight syringe.  One μL of 
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4:2 FTOH (as pure liquid) was added into vials to bring the initial concentration to 318 
mg/L.  A parallel set of vials was used to examine the effects of additional co-substrate 
on FTOH transformation.  N-octane (1 % final concentration) or 1-butanol (2 mM) was 
supplied as a co-substrate to vials containing P. oleovorans or P. butanovora and 4:2 
FTOH.  Cell-free controls and killed (sterile) controls were also used to ensure study 
integrity.  For killed controls, 100 μL of concentrated sulfuric acid was used to inactive 
the resting cells.  All samples and controls were in duplicate.  The vials were 
incubated on a shaker at 150 rpm in a 30°C dark room.  The vials were sacrificed over 
different time points: 0, 12 and 24 h for 6:2 and 8:2 FTOH transformation by P. 
oleovorans, 0, 24 and 48 h for 4:2 FTOH transformation by P. oleovorans and 0, 1 and 3 
d for 4:2, 6:2 and 8:2 FTOH transformation by P. butanovora.  At each sampling time 
point, 2 mL of hexane was added to the vials to stop transformation and extract the 
remaining FTOH.  After overnight extraction, a gas tight syringe was used to transfer 
the hexane layer to clean capped GC amber vials (1.5 mL) which were then stored at -
20°C for later GC/MS analysis.  The aqueous layer in the old sample vials (i.e. 22 mL-
glass vials) was preserved at 4°C and later used for fluoride ion measurement.  Short-
term transformation experiments were also conducted for 6:2 FTOH and 8:2 FTOH.  
Experiments were conducted similarly as described for 4:2 FTOH transformation tests, 
except using 6:2 FTOH or 8:2 FTOH.  Two microliters (or 3300 μg) of 6:2 FTOH was 
added.  For 8:2 FTOH transformation tests, 5 μL of 8:2 FTOH stock solution (40g/L in 
95% ethanol) (or 200 μg) was used. 
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3.2.4 Long-term experiments for determining FTOH transformation products 
 
Long-term experiments for determining FTOH transformation products were 
performed in a series of 120-mL glass bottles containing cell suspension (10 mL), 6:2 
FTOH (or 8:2 FTOH), and one carbon source.  The cell suspensions were prepared as 
described in the biotransformation tests for 4:2 FTOH.  0.05 % n-octane and 2 mM 1-
butanol were added for cell suspensions of P. oleovorans and P. butanovora, 
respectively.  The 120-mL glass bottles were first sealed with butyl rubber septa and 
aluminum caps before FTOH addition.  Ten microliter of 8:2 FTOH stock solution (2 
g/L in 50% ethanol) or 6:2 FTOH stock solution (4.125 g/L in 50 % ethanol) was added 
to the bottles using a 25 μL-gas-tight syringe.  Killed controls, containing acid-killed 
cells (by adding 50 μL of concentrated sulfuric acid) and 6:2 or 8:2 FTOH, were also 
prepared to assess parent compound recovery during FTOH transformation.  Live 
controls, containing cell suspension and one of the additional carbon sources (1-butanol 
or n-octane) and 50 % ethanol, were also used to monitor oxygen condition.  Oxygen 
concentrations in the headspace of live controls were determined using a headspace 
oxygen analyzer (Model 905 from Quantek Instruments, Grafton, MA).  The bottles 
were incubated on a shaker at 150 rpm in a 30 °C dark room.  At each of following 
sampling points (0, 0.5, 1, 3, 7, 14, 28 days), two live samples and two killed control 
bottles were sacrificed for solvent extraction.  Twenty milliliters of acetonitrile were 
added to each of the bottles to extract the remaining FTOH and potential metabolites in 
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the 10-mL cell suspension.  The extraction was carried out for 3 days at 50 °C with 
~150 rpm shaking.  After the extraction, each bottle was resealed with a new septum 
and preserved in a freezer (-50°C).  The spent septum from each bottle was placed into 
a new glass bottle and extracted twice with 5 mL acetonitrile for 3 days at 50 °C. The 
two extracts from the spent septum were pooled together with the extract from the liquid 
sample.  The combined extract was then filtered through a 0.45-μm pore size filter disk 
and the filtrate was collected and analyzed by LC/MS/MS.  Fluoride concentrations 
were not determined due to the small quantities of FTOHs applied initially and the 
limitation of detection limit of the Orion 96-09BNWP ion-selective electrode.  
 
3.2.5 Fluoride measurement 
 
The aqueous samples from the short-term FTOH transformation tests were first 
filtered through a 0.22 μm-pore size filter to remove the cell debris before use.  The 
filtrate was used to determine fluoride ion concentrations using an Orion 96-09BNWP 
ion-selective electrode (Thermo Scientific, Beverly, MA) following the manufacturer’s 
protocol.  Fluoride standard solutions, ranging from 2~20 mg/L, were prepared by 
diluting a certified fluoride standard solution (100 mg/L, Thermo Scientific, Beverly, 
MA) in the corresponding growth media.   
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3.2.6 GC/MS and GC/ECD analysis 
 
The concentration of 4:2 FTOH was determined using an Agilent Technologies 
6890N gas chromatograph (GC) coupled with a 5973N mass selective detector (Agilent 
Technologies) under full-scan positive electron impact mode.  The GC unit was 
equipped with a DB-5 column (30 m × 0.25 mm × 0.25 μm film thickness, Agilent 
Technologies).  The oven temperature program was modified from Russell et al. [34] as 
follows: 50 °C for 2 min, with a first ramp at 20 °C min
-1
 to 210 °C and a second ramp at 
50 °C min
-1
 to 280 °C, and then held at 280 °C for 3 min.  One microliter hexane 
extract from each sample was injected into the GC/MS system.  The injector 
temperature was 150 °C and the detector temperature was 280 °C.  Helium was used as 
the carrier gas at a flow rate of 1.2 mL min
-1
.  The 4:2 FTOH used for the 
transformation test was used to make standard solutions by serial dilution in hexane.  A 
linear calibration curve was obtained for 4:2 FTOH from 0.298 to 2.385 μg (R2>0.99).  
The hexane extracts from the transformation tests were also used for screening 
metabolites potentially produced during 4:2 FTOH biotransformation.  The screening 
was performed by using an Agilent 6890 series gas chromatograph equipped with a DB-
1 MS capillary column (30m × 0.25 mm × 0.25μm film thickness) and an electron 
capture detector (ECD).  The oven temperature program was 45°C for 2 min, ramping 
at 10 min
-1
 to 95 °C held for 5 min, and ramping at 30 °C min
-1
 to 250 °C.  The injector 
temperature was 150 °C and the detector temperature was 300 °C.   
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3.2.7 LC/MS/MS analysis 
 
LC/MS/MS analysis was used to identify and quantify metabolites produced 
during 6:2 and 8:2 FTOH biotransformation.  Acetonitrile extracts obtained from the 
120-mL bottle samples were analyzed as previously described [18] with some 
modifications.  The LC/MS/MS system (Micromass Quattro Micro and Waters 2795 
HPLC) was operated in negative electrospray ionization mode with multiple reaction 
monitoring.  Each extract was spiked with 50 μL/mLof sample and an internal standard 
solution containing 200 ng/mL of [1,2-
13
C] PFHxA (M+2 PFHxA) and 5000 ng/mL of 
[1,1,2,2-D; 3-
13
C] 6:2 FTOH (M+5 6:2 FTOH) for quantification of 6:2 FTOH and 
metabolites.  In particular, the [1,2-
13
C] PFHxA internal standard was used for 
quantification of PFBA, PFPeA, PFHxA, PFHpA, 6:2 FTCA, 6:2 FTUCA, 5:3 acid, 4:3 
acid, and 5:3 Uacid.  The [1,1,2,2-D; 3-
13
C] 6:2 FTOH internal standard was used for 
quantification of 6:2 FTOH, 5:2 ketone, and 5:2 sFTOH.  The same concentrations of 
[1,2-
13
C] PFOA (M+2 PFOA) and [1,1,2,2-D; 3-
13
C] 8:2 FTOH (M+5 8:2 FTOH) were 
spiked into each sample extract for quantification of 8:2 FTOH and metabolites.  The 
[1,2-
13
C] PFOA internal standard was used for quantification of PFHxA, PFHpA, PFOA, 
PFNA, 8:2 FTCA, 8:2 FTUCA, 7:3 acid, and 7:3 Uacid.  The [1,1,2,2-D; 3-
13
C] 8:2 
FTOH internal standard was used for quantification of 8:2 FTOH, 7:2 ketone, and 7:2 
sFTOH. Unlike the previous method [18], the extracts were not acidified before 
LC/MS/MS analysis.  The detection limit of FTOH and transformation products and 
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other detailed information on instrumental parameters was included in Table A3.2 & 
A3.3 in Appendix. 
 
3.3 Results and discussion 
 
3.3.1 Biotransformation and biodefluorination of 4:2 FTOH by P. oleovorans 
 
Biotransformation of 4:2 FTOH was observed by P. oleovarans within 48 h in 
the absence and presence of n-octane (Fig. 3.1 and Table A3.1 in Appendix) along with 
an increase amounts of fluoride concentration in the samples.  Currently, no 
information is available regarding 4:2 FTOH biotransformation pathways and potential 
transformation products.  The extent of 4:2 FTOH biodefluorination and 4:2 FTOH 
transformation products were not determined due to the lack of metabolite standards.  
However, based on the amounts of fluoride released, 4:2 FTOH was biodefluorinated 
more extensively in the absence of n-octane (Table A3.1).  The addition of n-octane 
inhibited FTOH defluorination by more than two-fold (Table A3.1).  This indicates that 
P. oleovorans prefers n-octane as its carbon source over 4:2 FTOH. Table A3.1 in the 
Appendix presents how defluorination was calculated and compares defluorination of 
4:2 FTOH by these two strains in the absence and presence of additional carbon sources.  
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Even though P. oleovorans can defluorinate 4:2 FTOH, the bacterium cannot grow on 
4:2 FTOH as the sole carbon source. 
 
3.3.2 Biotransformation and biodefluorination of 4:2 FTOHs by P. butanovora 
 
Similarly, P. butanovora showed ability to biotransform 4:2 FTOH in the 
absence and presence of 1-butanol (Fig. 3.1 and Table A3.1) to produce fluoride.  
However, the effects of 1-butanol on 4:2 FTOH defluorination by P. butanovora were 
less pronounced than that of n-octane.  For example, on day 3, 149.5 μg (7.9 μmol) 
fluoride was released in the absence of 1-butanol versus 111.5 μg (5.9 μmol) fluoride 
with the addition of 1-butanol.  The amounts of fluoride released correspond to a 
defluorination potential of 37.3% in the absence of 1-butanol and 32% in the presence of 
1-butanol (Table A3.1). 
 
3.3.3 Potential metabolites during 4:2 FTOH biotransformation 
 
GC/ECD analysis was used to screen metabolites formed during 4:2 FTOH 
biotransformation by these two strains.  As shown in Figure A3.1 in Appendix, in the 
absence of n-octane, two new peaks were detected during 4:2 FTOH biotransformation 
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[Substrate Degrading Rate] 
 
4:2 FTOH biodegraded (μmole) 
Initial biomass (protein, μg) x Time (day) 
by P. oleovorans.  When 4:2 FTOH was biotransformed by P.butanovora, five new 
peaks were observed in the samples without 1-butanol and only three new peaks were 
detected in the samples with 1-butanol (Fig. A3.2 in Appendix).  These chromatographs 
suggest that 4:2 FTOH was transformed by these two strains through different pathways 
and that the degradative enzymes expressed by these two strains might have different 
affinities toward 4:2 FTOH and its metabolites.  Unfortunately, due to lack of authentic 
metabolite standards for LC/MS/MS analysis, the identities of these fluorinated and 
other potential non-fluorinated metabolites were not determined in this study.  
 
 
 
 
 
 
 
 
 
 
Fig. 3.1. 4:2 FTOH transformation by P. oleovorans and P. butanovora.  P. oleovorans 
and P. butanovora were able to transform 4:2 FTOH in the absence and presence of 
additional carbon sources (n-octane for P. oleovorans and 1-butanol for P. butanovora).  
Initial mass of 4:2 FTOH applied is 1590 μg (6.0 μmol) in 5 mL bacterial cell 
suspension.  The bars represent ranges of duplicate samples. 
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3.3.4 Transformation products for 6:2 and 8:2 FTOHs 
 
Similar to 4:2 FTOH, GC/ECD analysis revealed new peaks (peaks 1 and 2) 
during short-term transformation tests if the 6:2 and 8:2 FTOH biotransformation by P. 
oleovorans (Figs. A3.3 and A3.4 in Appendix).  To identify these metabolites, long-
term experiments were conducted and samples were analyzed by LC/MS/MS.  Five to 
eight of 6:2 and 8:2 FTOH transformation products were identified and quantified by 
LC/MS/MS analysis (Fig. 3.2 for P. oleovorans and Fig. 3.3 for P. butanovora).  Over 
the course of FTOH biotransformation (28 days), 10 % (v/v) of oxygen in gas phase 
remained which is a half of the initial oxygen (~ 20 % in gas phase) in live control 
bottles (Fig. 3.2a and Fig. 3.3a); 103~109 % of 6:2 FTOH initially applied at day 0 and 
105~106 % of 8:2 FTOH initially applied at day 0 were still remained in sterile controls 
(Fig. 3.2b and Fig. 3.3b).  These results demonstrate the integrity of the experimental 
systems.  In the live samples (except the study with P. butanovora dosed with 6:2 
FTOH), the sum of FTOH and transformation products from LC/MS/MS analysis did 
not yield 100% of initial FTOH applied.  Approximately 40-54% of the initially applied 
FTOH loss may be due to two factors.  First, bound-residue (up to 25-30% of initial 
applied FTOH) formed between fluorinated chemicals and biological organic 
components catalyzed by bacterial enzymes made this fraction non-quantifiable by 
LC/MS/MS [17, 25].  Second, other potential metabolites formed during FTOH 
biotransformation were not quantified due to either lack of authentic analytical standards 
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or unknown identities.  Nonetheless, the total mass balance of this study is comparable 
to that of previous studies on FTOHs with microbial consortia [5, 18,33]. 
Eight metabolites were detected and quantified during 6:2 and 8:2 FTOH 
biotransformation by P. oleovorans, respectively (Figs. 3.2c-1 and 3.2c-2).  According 
to the quantity of each metabolite detected over time (Fig. 3.2c), a general trend of 
FTOH biotransformation was observed as follows.  From day 0 to day 3, P. oleovorans 
quickly transformed 6:2 and 8:2 FTOHs to n:2 FTCA, to n:2 FTUCA, to x:2 ketone, and 
then to x:2 sFTOH.   
(1) n:2 FTCA(n:2 fluorotelomer saturated carboxylic acid) 
F(CF2)nCH2COOH, n= 6 or 8 
(2) n:2 FTUCA (n:2 fluorotelomer unsaturated carboxylic acid) 
F(CF2)n-1CF=CHCOOH, n= 6 or 8 
(3) x:2 ketone 
F(CF2)xC(O)CH3;x= n-1, where n = 6 or 8 
(4) x:2 sFTOH (x:2 secondary alcohol) 
F(CF2)xCH(OH)CH3; x= n-1, where n = 6 or 8 
As the 6:2 and 8:2 FTOH concentrations decreased, these four metabolites 
continued to increase to reach their maximum on day 7 and remained little or no change 
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until day 14, and then decreased slightly on day 28.  Also, on day 3, PFCAs such as 
PFBA (perfluorobutyric acid) in 6:2 FTOH samples and PFHxA (perfluorohexanoic acid) 
in 8:2 FTOH samples appeared in trace amounts and increased slightly on day 28, 
accounting for 0.44 mol% and 0.62 mol% of initially applied 6:2 and 8:2 FTOHs, 
respectively.  The formation of PFBA from 6:2 FTOH or PFHxA from 8:2 FTOH 
indicates that three ─CF2─ groups were removed from 6:2 FTOH or 8:2 FTOH during 
biotransformation.  In contrast, PFHxA or PFOA is the major stable transformation 
product from 6:2 FTOH or 8:2 FTOH biotransformation, accounting for 2.8 mol% or 2.6 
mol% of initially applied 6:2 or 8:2 FTOH.  
The x:3 Uacid [x:3 unsaturated acid, F(CF2)xCH=CHCOOH; x= n-1, where n = 
6 or 8] and x:3 acid [F(CF2)xCH2CH2COOH], started to emerge on day 3.   The 
concentrations of x:3 Uacid continued to increase until day 14 and then decreased at the 
end of experiment on day 28, with 5:3 Uacid accounting for 9.1 mol% and 7:3 Uacid for 
2.9 mol% of initially applied 6:2 and 8:2 FTOHs, respectively.  However, the x:3 acid 
continued to increase on day 28, with 5:3 acid accounting for 4.7 mol% and 7:3 acid 
accounting for 1.8 mol%, respectively.  
Only five and six metabolites were detected during 6:2 and 8:2 FTOH 
biotransformation by P. butanovora, respectively (Figs. 3.3c-1 and 3.3c-2).  Similarly, 
within one day, P. butanovora quickly transformed 6:2 and 8:2 FTOHs to n:2 FTCA, n:2 
FTUCA, and x:2 ketone (Fig. 3.3c).  For samples with 6:2 FTOH, the concentrations of 
5:2 ketone increased throughout the experiment, whereas in samples with 8:2 FTOH, the 
48 
 
concentrations of 7:2 ketone increased fivefold by day 7 compared with day 1 and then 
decreased on day 28.  On day 3, new metabolites x:2 sFTOHs started to emerge and 
continue to increase until day 28.  Also, PFHxA (during 6:2 FTOH transformation) and 
PFOA (during 8:2 FTOH transformation) were identified on day 1 and increase slightly 
from day 7.  Interestingly, a trace amount of PFHxA was detected after day 7 during 
8:2 FTOH transformation and accounted for 0.45 mol% of initially applied 8:2 FTOH on 
day 28.  Contrary to P. oleovorans, no PFBA was detected during 6:2 FTOH 
biotransformation by P. butanovora.  At the end of experiments (day 28), the observed 
major intermediates included: n:2 FTUCA, x:2 ketone, and x:2 sFTOH.  PFHxA or 
PFOA is the major stable transformation product from 6:2 FTOH or 8:2 FTOH 
biotransformation, accounting for 2.9 mol% or 7.9 mol% of initially applied 6:2 or 8:2 
FTOH.  In contrast to P. oleovorans, no x:3 Uacid or x:3 acid was detected in P. 
butanovora samples dosed with 6:2 or 8:2 FTOH, suggesting that P. butanovora under 
these study conditions may lack enzymes capable of defluorinating n:2 FTUCA to x:3 
Uacid and then of reducing the latter to x:3 acid.   
 
3.3.5 Biotransformation pathways for 6:2 and 8:2 FTOHs 
 
Based on the metabolites detected in this study, two possible pathways for 6:2 
and 8:2 FTOH transformation were proposed (Fig. 3.4).  Pathway I leads to the 
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formation of major PFCAs and pathway II leads to x:3 acids and small amounts of 
shorter-chain PFCAs.  These two pathways share the same first three transformation 
steps before diverging into two different paths (Fig. 3.4).  In the first step of the 
transformation, 6:2 and 8:2 FTOHs were transformed into n:2 FTAL (not analyzed; an 
assumed intermediate, [24]), which was quickly transformed to n:2 FTCA.  Then 
n:2FTCA was further transformed to n:2 FTUCA, where the first defluorination reaction 
occurred.  This defluorination reaction involved hydrogen fluoride (HF) elimination [18, 
25].  
The second defluorination reaction occurred when n:2 FTUCA was transformed 
to x:2 ketone on pathway I, or to x:3 Uacid on pathway II.  By following the PFCA 
pathway I, x:2 ketone was further converted to x:2 sFTOH, and then to PFCAs via many 
unknown enzymatic steps.  As n:2 FTUCA [F(CF2)n-1CF=CHCOOH, n= 6 or 8] looks 
similar to long-chain fatty acid, β-oxidation has been previously speculated for the 
transformation.  However, due to the deficiency of protons in the β-carbon position, n:2 
FTUCA cannot be the direct substrates for the β-oxidation [32].  This view is supported 
by recent finding that PFBA was formed from 5:3 Uacid in activated sludge through 
one-carbon removal pathways [35] and not formed from 5:2 sFTOH [17].  Yet, it is still 
unclear if PFHxA observed in this study with 8:2 FTOH-dosed P. butanovora strain was 
transformed directly from 7:2 sFTOH or from other unknown 8:2 FTOH metabolites.  
Previous work in mixed bacterial culture and soils [24] hypothesized that PFHxA was 
from 8:2 FTUCA or from 7:3 Uacid biotransformation.  These results indicate that 
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PFHxA (~ 0.45 mol% of initially applied 8:2 FTOH) detected in P. butanovora could 
come from 8:2 FTUCA or other unknown metabolites rather than 7:3 Uacid, which was 
not detected along with PFHxA.  The formation of x:3 acids via pathway II is rather 
simple and involved only two enzymatic steps.  The n:2 FTUCA was first defluorinated 
to x:3 Uacid via a dehalogenase.  The x:3 Uacid was then converted to x:3 acid 
catalyzed by a dehydrogenase or saturase.  The results from this study clearly 
demonstrated that P. oleovorans transformed 6:2 and 8:2 FTOHs using both PFCA 
pathway I and x:3 acid pathway II.  On the other hand, P. butanovora utilized only the 
PFCA pathway I for FTOH transformation, which was supported by the lack x:3 Uacid 
and x:3 acid in samples dosed with 6:2 or 8:2 FTOH.  
The production of PFHxA, resulting from removal of three –CF2– groups from 
8:2 FTOH by P. oleovorans, is consistent with previous findings that 8:2 FTOH can be 
transformed into perfluorohexanoic acid and other perfluorohexyl-containing substances 
by different microbial consortia [25, 32].  As described earlier, other shorter-chain 
perfluorinated products could be formed, but were not identified due to the lack of 
authentic standards.  This work suggests that a complete enzyme system does exist in a 
pure microbial strain as in a consortium to remove multiple –CF2– groups from FTOHs.  
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Fig. 3.2. Time trend of metabolite (transformation product) formation during 6:2 and 8:2 
FTOH biotransformation by P. oleovorans.  (a) Changes in oxygen concentrations 
during FTOH biotransformation; (b) changes of 6:2 and 8:2 FTOH concentration during 
28 d in killed (sterile) controls; (c) changes of different metabolite concentrations during 
28 d in live samples dosed with 6:2 FTOH or 8:2 FTOH.  The transformation products 
in pathway I and II are grouped together in (c).  
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Fig. 3.2. Continued 
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Fig. 3.3. Time trend of metabolite formation during 6:2 and 8:2 FTOH biotransformation 
by P. butanovora.  (a) Changes in oxygen concentrations during FTOH 
biotransformation; (b) changes of 6:2 and 8:2 FTOH concentrations during 28 d in killed 
controls; (c) changes of different metabolite concentrations during 28 d in live samples 
dosed with 6:2 FTOH or 8:2 FTOH.  The transformation products in pathway I and II 
are grouped together in (c). 
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Fig. 3.3. Continued 
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Fig. 3.4. 6:2 FTOH (n = 6) and 8:2 FTOH (n = 8) biotransformation pathways by P. 
oleovorans and P. butanovora.  Pathway I leads to major PFCAs (perfluorinated 
carboxylic acids) whereas pathway II leads to 5:3 acid or 7:3 acid and small amounts of 
shorter-chain PFCAs.  P. oleovorans utilized both pathway I and II; while P. 
butanovora only utilized pathway I.  The compound in the dashed bracket is an 
assumed intermediate that was not quantified.  The double arrows indicate multiple 
biotransformation steps.  Dash arrows indicate pathways that may or may not exist. 
? 
F
-
 
Two 
-CF2- 
F(CF2)7CHOHCH3 
(7:2 sFTOH) 
F(CF2)x-2COO
-
 
(PFBA or PFHxA, 
x= n-1, n = 6 or 8) 
Two 
CF2- 
F(CF2)nCH2CH2OH 
(6:2 or 8:2 FTOH, 
n= 6 or 8) 
F(CF2)nCH2COO
-
 
(6:2 or 8:2 FTCA) 
F(CF2)nCH2CHO 
(6:2 or 8:2 FTAL) 
F(CF2)n-1CF=CHCOO
-
 
(6:2 or 8:2 FTUCA) 
F(CF2)xC(O)CH3 
(5:2 or 7:2 ketone, 
x=n-1, n=6 or 8) 
F(CF2)xCH=CHCOO
-
 
(5:3 or 7:3 Uacid, 
x=n-1, n =6 or 8) 
F(CF2)5CHOHCH3 
(5:2 sFTOH) 
F(CF2)7COO
-
 
(PFOA) 
F(CF2)5COO
-
 
(PFHxA) 
F(CF2)xCH2CH2COO
-
 
(5:3 or 7:3 acid) 
P. oleovorans 
P. butanovora 
P. oleovorans 
(n=8) (n=6) 
P
F
C
A
s 
p
at
h
w
ay
 (
I)
 
X:3 acid pathway (II) 
F- 
F- 
56 
 
4. AEROBIC BIOTRANSFORMATION OF 6:2 FLUOROTELOMER 
ALCOHOL BY ALKANE- AND FLUOROACETATE-DEGRADING BACTERIA 
 
4.1 Introduction 
 
The worldwide detection of perfluorocarboxylic acids [PFCAs, F(CF2)mCOOH, 
2 < m < 8][14, 119-124], particularly perfluorooctanoic acid (PFOA, m=7), has 
prompted intensive research efforts to better understand their sources [112], fate, and 
transport [125, 126] in the environment.  Under high experimental dosage, PFOA is 
known to induce peroxisome proliferation in male mice [27], cause development toxicity 
in mouse neonates [28] and rats [29], and significantly increase mortality in pups [30].  
Early studies reported that 8:2 fluorotelomer alcohol [8:2 FTOH, F(CF2)8CH2CH2OH] is 
a raw material for the manufacture of fluorinated surfactants and fluorinated polymers 
and attributed to be a precursor of PFOA [127].  Accordingly, in an effort to eliminate 
the global production of PFOA and its precursors [16], the manufacturers recently 
adopted 6:2 FTOH [F(CF2)6CH2CH2OH] as a raw material to manufacture FTOH-based 
products [17, 18].  Therefore, a better understanding of 6:2 FTOH biodegradation 
potential is essential for assessing its fate and transport in the environment.  
Previous research efforts reported biodegradation pathways and novel 
metabolites (transformation products) of 8:2 FTOH in various environmental matrices 
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[24, 25, 31,32].  Recently, a few studies observed biodegradation of 6:2 FTOH in soils, 
activated sludge, and sediment [17, 18, 128], and by pure cultures of two alkane-
degrading Pseudomonas strains [31].  Compared with 8:2 FTOH biodegradation 
observed in soils, activated sludge, and sediment, a faster 6:2 FTOH degradation and 
more extensive breakdown products were observed [17, 18, 128].  PFPeA 
[perfluoropentanoic acid, F(CF2)4COOH], PFHxA [perfluorohexanoic acid, 
F(CF2)5COOH], and 5:3 polyfluorinated acid [5:3 acid, F(CF2)5CH2CH2COOH] were 
major metabolites formed during 6:2 FTOH degradation in aerobic soils.  A later 90-
day study using activated sludge suggested that 5:3 acid can be further defluorinated and 
decarboxylated via novel ―one-carbon removal pathways‖ to form metabolites with 
shorter carbon-chain length.  For example, through these novel pathways, 5:3 acid can 
be degraded into 4:3 acid as a result of removing one CF2 group from 5:3 acid.  The 
reactions for one –CF2– removal can continue for 4:3 acid to form 3:3 acid.  5:3 acid 
was first converted to 5:3 Uacid [F(CF2)5CHCHCOOH], then α-OH 5:3 acid 
[F(CF2)5CH2CH(OH)COOH] (as the dominant intermediate metabolite), 5:2 acid 
[F(CF2)5CH2COOH], 5:2 Uacid [F(CF2)4CFCHCOOH], and then to several poly- and 
per-fluorinated carboxylates (PFPeA, PFBA [perfluorobutyric acid, F(CF2)3COOH], 4:3 
acid [F(CF2)4CH2CH2COOH] and 3:3 acid [F(CF2)3CH2CH2COOH])[18, 25, 35]. These 
results suggest that more extensive defluorination of 6:2 FTOH is possible through the 
one-carbon removal pathways and other yet to be identified novel microbial 
defluorination mechanisms.  
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Our previous study [31] demonstrated that two pure alkane-degrading bacteria, 
P. oleovorans and P. butanovora defluorinated 6:2 FTOH via one or two degradation 
pathways, called PFCA pathway and x:3 acid pathway.  In 28-day experiments, P. 
oleovorans used both pathways to degrade 6:2 FTOH to produce a wide range of 
metabolites: 5:2 ketone [dominant metabolite, F(CF2)5C(O)CH3], 5:2 sFTOH 
[F(CF2)5CH(OH)CH3], PFHxA, PFBA and 5:3 acid.  In contrast, 6:2 FTOH 
degradation by P. butanovora, produced PFCAs but not 5:3 acid, suggesting that only 
PFCA pathway was involved in producing 5:2 ketone, 5:2 sFTOH, and PFHxA.  The 
two pure strains did not generate short-chain odd-numbered PFCAs (e.g., PFPeA) or 4:3 
acid as observed in 6:2 FTOH degradation by mixed bacterial cultures [17], implicating 
that other microorganisms might be able to degrade 6:2 FTOH via different pathways.  
As 5:3 acid degradation requires longer incubation time (up to 90 days) [35], it was 
unclear if 5:3 acid (the key the metabolite from 6:2 FTOH degradation viax:3 pathway) 
could be further transformed by P. oleovorans or other candidate microorganisms.   
Mycobacterium vaccaeJOB5 (Gram-positive alkane-degrading bacteria) and P. 
fluorescens DSM 8341 (fluoroacetate-degrading bacteria) were tested to determine the 
possibility of 6:2 FTOH degradation by these pure strains other than the P. oleovorans or 
P. butanovora.  M. vaccae JOB5 utilizes a wide range of linear alkanes (C1-C22) as 
growth substrates [43].  M. vaccae JOB5 is known to degrade trichloroethylene[66], 
BTEX (benzene, toluene, ethylbenzene, and xylenes) [83], tertiary butyl alcohol (TBA) 
[82], or 1,4-dioxane [84] when grown on propane; chloroform [67] after grown on 
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butane; and methyl tertiary butyl ether (MTBE) [85] after grown on n-octane.  M. 
vaccae JOB5 was selected to determine if C1-C22 alkane-degrading bacterium can also 
degrade and defluorinate 6:2 FTOH to different extents.  P. fluorescens DSM 8341 can 
grow on fluoroacetate [F(CH2)COO-]as a sole carbon source and express fluoroacetate-
dehalogenase to cleave off the C-F bond of fluoroacetate [59].  Among various 
dehalogenases studied [47, 88-95], fluoroacetate-dehalogenase is the only enzyme that 
specifically hydrolyzes the C-F bond [56].  Given that P. fluorescens DSM 8341can 
express fluoroacetate-dehalogenase and that the structure of fluoroacetate is similar to 
fluorinated acids (like 5:3 acid or short-chain PFCAs), experiments were conducted to 
determine if this fluoroacetate-degrading bacterium can degrade 6:2 FTOH.  
This study also examined if the extent of 6:2 FTOH biodegradation can be 
improved by providing different co-substrates.  It is hypothesized that the addition of 
different co-substrates can induce needed degradative enzymes and/or provide needed 
reducing power if the degradation of 6:2 FTOH is reducing energy dependent.  Three 
different co-substrates, dicycloproplyketone (DCPK), formate, and lactate were used.  
DCPK, a gratuitous inducer of alk genes on OCT plasmid in P. oleovorans [74, 75], was 
provided to induce the expression of alkane monooxygenases.  Formate was added as 
an external reducing energy source.  Lactate, an odd-numbered carbon source, is known 
to induce enzymes in P. butanovora to produce pyruvate and odd-number fatty acids 
[71].  In P. butanovora, lactate serves as an effective exogenous reductant for the 
soluble butane monooygenase (sBMO) during co-metabolism [72, 80] and pyruvate, an 
60 
 
antioxidant, might protect the cells from damages caused by cooxidation [71].  Thus, 
lactate was selected and added to the degradation experiments containing P. butanovora. 
Additional experiments were conducted to study the degradation potential of 5:3 
polyfluorinated acid (a key metabolite during 6:2 FTOH degradation) by  P. oleovorans 
(alkane-degrading bacteria) and P. fluorescens DSM 8341 (fluoroacetate-degrading 
bacteria).  
 
4.2 Materials and methods  
 
4.2.1 Chemicals   
 
6:2 FTOH (1H, 1H, 2H, 2H-perfluorooctanol, CAS # 647-42-7, 97 % pure) was 
obtained from Alfa Aesar (Lancashire, UK).  5:3 Acid (C5F11CH2CH2CO2H, > 96% 
purity) was synthesized by DuPont Inc.,Wilmington, DE.  The 5:3 acid contains 
approximately 4% of non-fluorinated impurities, which has no potential to produce 
transformation products that were observed during 5:3 acid degradation. 1-Butanol 
(99.4 % pure) was purchased from Fisher Scientific (Fair Lawn, NJ) and n-octane (97 % 
pure) from Acros Organics (Geel, Belgium).  Sodium fluoroacetate (SFA) was 
purchased from Pfaltz & Bauer, Inc (Waterbury, CT) and sodium chloroacetate (SCA) 
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from Sigma-Aldrich (Louis, MO).  DCPK was obtained from Oakwood Products, Inc 
(West Columbia, SC),sodium formate from MP Biomedicals, Inc (Solon, Ohio), sodium 
lactate from Alfa Aesar (Ward Hill, MA), and sodium citrate from Mallinckrodt 
Chemicals (Phillipsburg, NJ).  Acetonitrile (> 99% pure) was purchased from Acros 
Organics (Geel, Belgium), ethanol (95% pure) from IBI scientific (Peosta, IA), and 
sodium hydroxide from EM Science (Gibbstown, NJ).  6:2 FTOH and 5:3 acid was 
prepared in 50% ethanol (ethanol:water = 1:1) as stock solution to be dosed into 
individual bacterial culture samples.   
For LC/MS/MS analysis, perfluorinated carboxylic acid standards (PFBA, 
PFPeA, PFHxA, and PFHpA) were purchased from either Sigma-Aldrich (St. Louis, MO) 
or Synquest Laboratories (Alachua, FL); 6:2 FTOH was from Fluka (St. Louis, MO); 
and 5:2 ketone was from TCI America (Portland, OR). The 4:3 acid (C4F9CH2CH2CO2H; 
96% purity with C4F9CH2CH2COOCH2CH2CH2C4F9, as the major impurity) and α-OH 
5:3 acid [C5F11CH2CH(OH)COOH, 98%] were synthesized by DuPont.  The [M+5] 
PFHxA internal standard was from Wellington Laboratories (Guelph, Ontario, Canada). 
The rest of polyfluorinated acid standards used for quantitative analysis were 
synthesized by DuPont (Wilmington, DE).  All standards have a purity of + 97 %. 
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4.2.2 Bacterial strains and growth conditions 
 
P. oleovorans was purchased from America Type Culture Collection (ATCC 
number # 29347). P. oleovorans was grown in P1 medium [118] with 1% n-octane to an 
optical density at 660 nm (OD660) of 1.0 before harvested for experimental use.  The 
cells were centrifuged at 10,000 g for 5 min, washed twice with 0.1 M phosphate buffer 
(pH = 7), and the pellet was then resuspended in P1 medium for experimental use. P. 
butanovora was generously provided by Dr. Daniel J. Arp, Oregon State University.  
The cell suspension was prepared similarly to P. oleovorans.  Briefly, P. butanovora 
was pregrown in ATCC1581 medium [68] with 2 mM 1-butanol to OD600= 0.5-0.7 
before harvested for experimental use.  M. vaccaeJOB5 was generously provided by Dr. 
Robert Steffan, Shaw Environmental, Inc.(Lawrenceville, New Jersy).  Similarly, M. 
vaccae JOB5 was pregrown in NMS medium with 2 mM 1-butanol and 0.01 % yeast 
extract to OD600= 0.5-0.7 before use.  P. fluorescens (DSM 8341) was purchased from 
the German Collection of Microorganisms and Cell Cultures (DSMZ, Germany).  P. 
fluorescensDSM 8341 was grown in Luria Broth (LB) medium to obtain high cell 
density (over OD600 = 1.0).  The cells were centrifuged at 10,000 g for 5min, washed 
with 0.1 M phosphate buffer (pH = 7), and then re-grown in 457 mineral medium 
(Brunner) with 0.1% SFA and 0.05 % yeast extract to induce the expression of 
fluoroacetate dehalogenase.  The expression of fluoroacetate-dehalogenase was 
confirmed by the detection of fluoride in the growth medium.  The fluoride ion was 
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determined as described by Kim et al. [31] with anion-selective electrode (Orion 96-
09BNWP).Then, the fluoroacetate-degrading cells were centrifuged (10,000 g for 5min), 
washed (0.1 M phosphate buffer, pH = 7), and the pellets were resuspended in NMS 
medium to reach OD600 = 0.6 ~ 0.7for experimental use. 
 
4.2.3 6:2 FTOH biotransformation test 
 
The experiments for 6:2 FTOH biotransformation by each of the selected strains 
were performed in a series of 120-mL glass bottles containing cell suspension (10 mL), 
6:2 FTOH (4.125 g/L in 50 % ethanol), and one co-substrate (formate, lactate, or DCPK). 
Table 4.1lists the experimental labels and summary of each condition.  Experiments 
using P. oleovorans were supplied with 0.05 % n-octane and formate (1 mM) or DCPK 
(1 mM).  Experiments using P. butanovora were supplied with 2 mM 1-butanol with 
lactate (5 mM).  Experiments using M. vaccae JOB5 were supplied with 2mM 1-
butanol with or without formate (1 mM).  For experiments using P. fluorescens DSM 
8341, 1 g/L SCA and 0.05 % yeast extract with or without formate (1 mM) were used.   
Sample preparations including live and sterile controls, incubation, extraction, 
and instrumental analysis were the same as described in Chapter 3.  
 
64 
 
4.2.4 5:3 Polyfluorinatedacid degradation test 
 
The experiments for 5:3 acid biotransformation were conducted as described for 
the 6:2 FTOH degradation tests, except that 5:3 acid was used.  Only P. oleovorans and 
P. fluorescens DSM 8341were used in these experiments.  The chemicals added to each 
condition are summarized in Table 4.2.  
At each sampling point (0, 2, 7, 14, 28, 56 and 90 days), two active samples and 
two sterile control bottles were sacrificed for a two-step solvent extraction.  For the first 
extraction, twenty milliliters of acetonitrile was added to each bottle to extract the 
remaining 5:3 acid and potential metabolites in the 10-mL cell suspension.  The 
suspensions were extracted for 3 days at 50 °C with ~150 rpm shaking. After extraction, 
the bottles were centrifuged (× 300 g, 20 min) and the extracts passed through 0.22 µm-
pore sized filter paper, and the filtered extracts were stored at –50 °C for further analysis.  
The used filter paper and spent septum were added to each bottle containing the pellet, 5 
mL of acetonitrile and 0.15 mL of 1M NaOH for the second extraction.  The extraction 
was carried out at the same condition as the first extraction.  After the second extraction, 
the extracts were filtered through a 0.45-μm pore size filter disk and preserved at –50 °C 
separately.  Each extract from the first and second extraction was analyzed by 
LC/MS/MS individually.  
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4.2.5 Fluoride measurement and LC/MS/MS analysis 
 
The degradation of sodium fluoroacetate by P. fluorescens DSM 8341 was 
determined by measuring free fluoride ion concentration in the liquid medium.  The 
fluoride measurement and LC/MS/MS analysis were conducted as described in the 
previous work [31]. 
 
4.3 Results and discussion 
 
4.3.1 Biodegradation of 6:2 FTOH by 1-butanol grown M. vaccae JOB5 
 
A Gram positive alkane-degrading bacterium, M. vaccae JOB5, biodegraded 6:2 
FTOH into at least nine metabolites in the presence of 1-butanol (and formate) (Fig. 4.1).  
Almost 100 mol% of 6:2 FTOH applied at day 0 was recovered in the sterile controls, 
suggesting the integrity of the experimental systems and the suitability of the extraction 
method.  The average recovery was 76 mol% for active culture based on the sum of 
remaining 6:2 FTOH and quantifiable metabolites on day28 (Fig. 4.1).  The mass 
balance is comparable to that observed in previous FTOH degradation studies with 
microbial consortia [5, 18,33].  The missing portions could be attributed to two possible 
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factors: (i) non-extractable or non-quantifiable bound-residue formed between 
fluorinated compounds and biological organic components, and (ii) unknown 
metabolites that were not quantifiable due to lack of authentic analytical standards [17, 
25].  
Except for the formation of PFPeA, M. vaccae JOB5 produced the same 
transformation products as those observed in the degradation of 6:2 FTOH by P. 
oleovorans [31].  It was not surprising because M. vaccae JOB5 can use a wide range 
of substrates (C1-C22of n-alkane) [43] and alkB gene purified from this strain was similar 
to that of P. oleovorans (currently renamed as P. putida GPo1) [82].  However, the 
degradation of 6:2 FTOH by M. vaccae JOB5 was slower than those by P. oleovorans 
and P. butanovora [31].  Most of 6:2 FTOH was still remaining on day 3 (75.5 mol% 
of 6:2 FTOH remaining) and was not completely transformed on day 28 (4.6 mol% of 
6:2 FTOH remaining) (Fig. 4.1).  Formation of 6:2 FTCA [F(CF2)6CH2COOH] and 6:2 
FTUCA [F(CF2)5CF=CHCOOH] started on day 3 and reached 13.1 mol% and 32.2 mol% 
on day 28, respectively.  5:2 ketone, 5:2 sFTOH and PFHxA emerged on day 7 and 
increased to 14.8 mol%, 4.9 mol% and 0.89 mol% on day 28, respectively.  
Interestingly, an odd-numbered PFCA (PFPeA) was detected at a trace amount (0.26 
mol%) on day 28, which was not detected with P. oleovorans.  Additionally, lower 
levels of 5:3 acid (3.4 mol%), 5:3 Uacid (1.1 mol%) and PFBA (0.37 mol%) 
accumulated from day 3until day 28.  
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Table 4.1. Characteristics of four pure strains and experimental conditions for 6:2 FTOH biotransformation. 
Type of strain Strain name 
Enzyme induced based on the 
experimental conditions 
Co-substrate added during 
degradation tests 
Sample 
Label 
Alkane-degrading bacteria 
P. oleovorans Alkane monooxygenase 
n-octane A1 
n-octane + formate A2 
n-octane + DCPK A3 
P. butanovora Soluble butane monooxygenase 
1-butanol B1 
1-butnaol + lactate B2 
M. vaccaeJOB5 Monooxygenases 
1-butanol C1 
1-butanol + formate C2 
Fluoroacetate-degrading bacteria 
P. fluorescens 
DSM 8341 
Fluoroacetate-dehalogenase 
SCA+ YE D1 
SCA + YE + formate D2 
 
 
Table 4.2. The experimental conditions for 5:3 acid biotransformation. 
 
 
 
 
 
 
Strain Target compound 
Co-substrateadded during 
degradation tests 
P. oleovorans 
5:3 acid dissolved in ethanol 
n-octane 
DCPK 
DCPK + (sodium) citrate* 
P. fluorescens DSM 8341 
SFA+ YE 
SFA + YE + formate 
*DCPK induced alkane hydroxylase efficiently in the presence of citrate (non-alkane 
carbon source) [129] 
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The presence of formate (reducing energy) did not affect the degradation pattern, 
rate or the metabolites produced(Fig 4.1b).  Unlike P. butanovoa, it was unclear if 1-
butanol can effectively induce butane monooxygenases (BMO) in the strain JOB5.  As 
the strain JOB5 was pregrown and also supplemented with 1-butanol for 6:2 FTOH 
degradation tests, it was possible that BMO and/or alkane monooxygenase were not 
expressed or present at low levels which would explain why the strain JOB5 degraded 
6:2 FTOH at slower pace that P. butanovora [31].  Additional 6:2 FTOH experiments 
using butane-grown JOB5 with the addition of butane are needed. 
 
4.3.2 Biodegradation of 6:2 FTOH by P. fluorescens DSM 8341 
 
P. fluorescens DSM 8341, a fluoroacetate-degrading bacterium, transformed 6:2 
FTOH into at least nine metabolites (Figs. 4.2a and 4.2b).  Compared to the results of 
6:2 FTOH degradation experiments using P. oleovorans and P. butanovora [31], 
degradation of 6:2 FTOH was slower by P. fluorescensDSM8341.  The transformation 
products were the same as those observed for P. oleovorans, except for two odd-
numbered PFCAs: PFPeA and PFHpA.   
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Fig. 4.1. Biotransformation of 6:2 FTOH by M. vaccae JOB5 in the presence of a) 1-
butanol and b) 1-butanol and formate.  The solid square shows the decrease of 6:2 
FTOH in samples and the solid diamond represents 6:2 FTOH in sterile controls (killed 
controls, KC) taken intermittently on days 0, 3, 14 and 28.  The portion of metabolites 
in samples over time is described with different colors in mole %of 6:2 FTOH applied at 
day 0. 
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A similar degradation pattern was observed in the presence and absence of 
formate (Fig. 4.2a and 4.2b).  The degradation of 6:2 FTOH did not occur until day 1; 
however, the amount of 6:2 FTOH decreased dramatically to 38.6 mol% on day 3, to 2.1 
mol% on day 7,then undetectable on day 28.  As 6:2 FTOH quickly decreased after day 
3, 6:2 FTCA (53.8 mol% to 67.4 mol%) and 6:2 FTUCA (9.7 mol% to 14.9 mol%) 
increased significantly from day 3 to day 14.  On day 28, 6:2 FTCA decreased to 38.2 
mol%, but 6:2 FTUCA was still increasing (15.6 mol%), suggesting that the 
defluorination step from 6:2 FTUCA to 5:3 U acid was inefficient compared with other 
bacterial strains studied so far.  Meanwhile, other metabolites, 5:2 ketone, 5:2 sFTOH, 
PFHxA and PFPeA, also appeared on day 3.  The amounts of these metabolites 
continued to increase after day 3:20.7 mol% for 5:2 ketone, 27.4 mol% for 5:2 sFTOH, 
1.5 mol% for PFHxA, and 0.57 mol% for PFPeA on day 28.  5:3 Uacid and 5:3 acid 
accounted for 0.25 mol% and 4.7 mol% on day 28, respectively.    
PFHpA (0.03 mol%) was detected for the first time in 6:2 FTOH degradation by 
bacterial strain.  This trace level of PFHpA could come from impurities, rather than 6:2 
FTOH aerobic biotransformation.  If PFHpA indeed came from 6:2 FTOH, a possible 
mechanism for PFHpA formation is the α-oxidation of 6:2 FTCA.  However, a 
previous study examining FTOH metabolic products in rat hepatocytes suggested that α-
oxidation of 6:2 FTCA is not possible or unfavorable [130].  It was believed that HF 
elimination of 6:2 FTCA to produce 6:2 FTUCA is a more favorable reaction than α-
oxidation of 6:2 FTCA, which requires α-hydroxylation of 6:2 FTCA [130].  In the 
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presence of formate, PFBA(a shorter-chainPFCA) was detected on day 28 (Fig. 4.2b), 
suggesting that formate facilitated P. fluorescens DSM 8341 to remove multiple –CF2– 
groups from 6:2 FTOH.  The production of PFBA could come from 5:3 acid 
defluorination via the one-carbon removal pathway, or from 5:2 sFTOH degradation 
through unknown degradation pathways.  More research is needed to elucidate the 
degradation pathways leading to PFBA.  
 
4.3.3 Effects of co-substrate on 6:2 FTOH biotransformation by P. oleovorans 
 
Based on our previous work [31], these experiments were conducted to 
determine if addition of co-substrates can enhance 6:2 FTOH degradation by P. 
oleovorans.   Experiments were conducted with the addition of formate (as additional 
substrate and/or reducing energy source) or DCPK (as an alkane hydroxylase inducer). 
As displayed in Figure 4.3a, P. oleovorans was able to degrade > 90 % of the 
available 6:2 FTOH within 3 days (7.7 mol% of 6:2 FTOH applied on day 0remained) 
and produced at least 8 metabolites in the presence of n-octane.  In the presence of 
formate or DCPK, six times faster degradation rate for 6:2 FTOH was observed (Figs. 
4.3b and 3c).  P. oleovorans transformed > 90% of 6:2 FTOH within 12 hours when 
formate or DCPK was present along with n-octane, 9.1 mol% and 5.1 mol% of 6:2 
FTOH remained on day 0.5, respectively.  
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Fig. 4.2. Biotransformation of 6:2 FTOH by P. fluorescens DSM 8341 in the presence of 
a) SCA and YE, and b) SCA, YE and formate.  The solid square shows the decrease of 
6:2 FTOH in samples and the solid diamond represents 6:2 FTOH in sterile controls 
(killed control, KC) taken intermittently on days 0, 3, 14 and 28.  The portion of 
metabolites in samples over time is described with different colors in mole% of 6:2 
FTOH applied at day 0. 
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In the presence of DCPK or formate, as 6:2 FTOH transformed quickly, the 
amount of 6:2 FTCA increased to ~ 7 mol% on day 0.5 and decreased to ~ 1 mol% on 28 
days.  About 27 mol% of 6:2 FTUCA was produced on day 0.5, accumulated to ~ 29 
mol% and decreased to ~ 26 mol% on day 28 (Fig. 4.3b and 3c).  The maximum 
observed quantity of 6:2 FTUCA (~ 29 mol%) was three times higher than that observed 
in sample with n-octane only (Fig. 4.3a).  Regardless of the presence of DCPK or 
formate, the quantities of metabolites (35-40%) produced via the PFCA pathway (i.e. 
summation of 5:2 sFTOH, 5:2 ketone and PFHxA) were similar to those observed in the 
presence of n-octane only (40%) (Fig 4.3a).  These results suggest that rapid 
transformation of 6:2 FTOH into 6:2 FTUCA is possible by adding DCPK to enhance 
the expression of enzymes involved in the first steps of 6:2 FTOH degradation or by 
adding formate to supplement needed reducing energy source to defluorinate 6:2 FTCA 
more efficiently .   
Two odd-numbered PFCAs (about 0.2 mol% of PFPeA and 0.02 ~ 0.07 mol% 
of PFHpA) were observed when DCPK or formate was provided.  In addition, 5:3 acid 
(1.7 ~ 2.1 mol%) and 5:3 Uacid (6.1 ~ 7.2 mol%) were produced in samples with DCPK 
or formate, while 4.7 mol% of 5:3 acid and 9.1 mol% of 5:3 Uacid were formed in 
sample with n-octane only).  The results support our previous finding that P. 
oleovorans has both pathway I and II (or PFCA pathway and x:3 pathway, respectively). 
This finding also suggests the presence of alternative pathways for producing odd-
numbered PFCAs. 
74 
 
4.3.4 Effects of co-substrate on 6:2 FTOH biotransformation by P. butanovora 
 
Previously, P. butanovora transformed 6:2 FTOH into at least 5 metabolites in 
the presence of 1-butanol, utilizing the pathway I (PFCA pathway) [31].  P. butanovora 
could transform > 95 % of 6:2 FTOH (1.7 mol% of 6:2 FTOH applied at day 0remained ) 
within 12 hours and 6:2 FTOH was not detected after 7 days (Fig. 4.4a) [31].  
Additional co-substrate lactate was added to examine if it provides needed reducing 
energy and the effects of odd-numbered carbon source on 6:2 FTOH biodegradation.  
Lactate was selected because it induces enzymes to produce odd-numbered fatty acids 
and serves as exogenous reductants for sBMO.  Pyruvate, the first product of lactate 
degradation, is an antioxidant that can protect cells from oxidative damages [71, 72,80] 
Unexpectedly, in the presence of lactate, the transformation of 6:2 FTOH was 
slower than that observed in samples with only 1-butanol.  Approximately 80 mol% of 
6:2 FTOH remained on day 0.5, followed by 0.77 mol% remained on day 7, and was 
undetectable on days 14 ~ 28 (Fig. 4.4b).  This seven times slower transformation is 
attributed to P. butanovora preference for lactate over 6:2 FTOH. However, 
transformation of 6:2 FTOH in the presence of lactate was much more diverse in terms 
of the number of metabolites detected. 
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Fig. 4.3. Biotransformation of 6:2 FTOH by P. oleovorans in the presence of a) n-octane 
(revised from [31]), b) n-octane and formate, and c) n-octane and DCPK.  The solid 
square shows the decrease of 6:2 FTOH in samples and the solid diamond represents 6:2 
FTOH in sterile controls (killed control, KC) taken intermittently on day 0, 3, 14 and 28.  
The portion of metabolites in samples over time is described with different colors in mol% 
of 6:2 FTOH applied at day 0.  
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Fig. 4.3. Continued 
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The most interesting finding of the experiments using P. butanovora and lactate 
was the detection of metabolites: PFPeA, PFHpA, 5:3 acid and 5:3 Uacid, which were 
not observed in previous study with P. butanovora with 1-butanoladded [31].  As 
lactate is an odd-numbered compound with a carboxylic acid at the terminal, P. 
butanovora expressed more diverse enzymes to utilize lactate than for 1-butanol.  Both 
5:3 acid and 5:3 Uacid (a product from 6:2 FTUCA defluorination or 5:3 acid 
degradation via one-carbon removal pathway) also have molecular structures with a 
carboxylic acid at the terminal. P. butanovora produced more 5:3 Uacid (38 mol% of 6:2 
FTOH applied at day 0) than P. oleovorans did (9.1 mol%) [35].  PFPeA accounted for 
0.24 mol% on day 28; a trace amount of PFHpA (0.0004 mol%) was detected on day 0.5 
but rapidly disappeared.  These results strongly suggest that the extent of 6:2 FTOH 
biodegradation by P. butanovora is substrate-dependent and an odd-numbered carbon 
substrate like lactate can promote 6:2 FTUCA defluorination to 5:3 Uacid and 
decarboxylation to PFPeA, respectively.   
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Fig. 4.4. Biotransformation of 6:2 FTOH by P. butanovora in the presence of a) 1-
butanol (revised from [31]) and b) 1-butanol and lactate.  The solid square shows the 
decrease of 6:2 FTOH in samples and the solid diamond represents 6:2 FTOH in sterile 
controls (killed control, KC) taken intermittently on days 0, 3, 14 and 28.  The portion 
of metabolites in samples over time is described with different colors in mol% of 6:2 
FTOH applied at day 0. 
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4.3.5 Degradation of 5:3 acid, a selected transformation product 
 
Another research effort was placed on determining if 5:3 acid can be further 
degraded by alkane- and fluoroacetate-degrading bacteria.  Since 5:3 acid is the major 
and the end product in x:3 degradation pathway (pathway II) during 6:2 FTOH 
biodegradation, it is expected that the production of PFCAs via PFCA pathway (pathway 
I) can be minimized if x:3 acid degradation pathway can be promoted.  Thus, two 
strains, P. oleovorans and P. fluorescens DSM 8341 were used and the 5:3 acid 
degradation experiments were conducted in the presence of different co-substrates. 
P. oleovorans was unable to show any significant degradation of 5:3 acid in the 
presence or absence of DCPK (data not shown).  However, in the presence of sodium 
fluoroacetate and yeast extract, P. fluorescens DSM 8341 could slightly transform 5:3 
acid into at least 6 metabolites (Fig. 4.5).   
During the first 14 days, 5:3 acid was converted to 5:3Uacid (up to 3.0 mol%).  
The reactions between 5:3 acid and 5:3 Uacid were believed to be reversible [17, 35].  
On day 28, 5:2 Uacid was detected (0.31 mol%) and then decreased over time.  
Production of 4:3 acid was first observed on day 14 (0.37 mol%), increased to 1.54 mol% 
on day 56, and then declined on day 90.From day 56 to day 90, PFPeA was detected and 
its amount increased to 0.36 mol%.  The molar yields of 4:3 acid and PFPeA are 9 and 
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15 time lower, respectively, than that in activated sludge [35], and 4:3 acid molar yield is 
comparable to that in soil dosed with 5:3 acid [18].   
A similar degradation pattern and metabolites were observed when formate was 
added (data not shown), suggesting that formate did not enhance 5:3 acid transformation 
by P. fluorescens DSM 8341. 
Based on the metabolites detected, these results suggest that P. fluorescens DSM 
8341could transform 5:3 acid via one-carbon removal pathways [35], although to a less 
extent compared with that in activated sludge. The ability of P. fluorescens DSM 8341 
to degrade 5:3 acid, if enhanced, could lead to a more complete defluorination of6:2 
FTOH by promoting synergy among various FTOH-degrading microorganisms in a 
mixed culture with proper co-substrates to enhance defluorination and decarboxylation 
(mineralization) of 6:2 FTOH. 
 
4.3.6 Modification of 6:2 FTOH biotransformation pathways 
 
Based on the results from this study, Figure 4.6 shows a revised 
biotransformation pathway for 6:2 FTOH [31].  The steps shared by all four strains 
under tested conditions are marked in red arrows: 6:2 FTOH is first converted into 6:2 
FTAL (not analyzed; an assumed intermediate [24]), 6:2 FTCA, and then to 6:2 FTUCA.  
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The first defluorination occurs via hydrogen fluoride (HF) elimination when 6:2 FTCA 
is converted into 6:2 FTUCA [18, 25].  PFHpA was detected in several samples 
containing P. oleovorans with n-octane and DCPK (or formate), P. fluorescens DSM 
8341 with SCA and YE (and formate) and P. butanovora with 1-butanol and lactate.  
However, whether PFHpA is originated from 6:2 FTCA is not clear since α-oxidation of 
6:2 FTCA is not favorable [130]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.5. 5:3 acid biotransformation by P. fluorescens DSM 8341 in the presence of 
sodium fluoroacetate and yeast extract.  The solid square shows the decrease of 5:3 acid 
in the sample and the solid diamond represents 5:3 acid in sterile control (killed control, 
KC) taken intermittently on day 0, 14, 56 and 90.  The portion of metabolites in the 
sample over time is described in bar charts with different colors in mol% of 5:3 acid 
applied at day 0. 
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In the pathway I (PFCA pathway), 6:2 FTUCA is converted to 5:2 ketone in 
which multiple enzymatic steps might be involved; the mechanisms for 8:2 FTUCA to 
7:2 ketone were proposed in previous study [131].  5:2 ketone is then converted to 5:2 
sFTOH, and finally to short PFCAs.  In the pathway II (x:3 acid pathway), 6:2 FTUCA 
is transformed into 5:3U acid, 5:3 acid, and PFPeA. 
Through pathway I (PFCA pathway), 5:2 sFTOH can be converted into three 
possible products: PFHxA, PFPeA, and PFBA.  The conversion of 5:2 sFTOH to 
PFHxA was proposed earlier in previous studies [17, 31] and confirmed again in this 
study.  The production of PFHxA was only observed in aerobic soil when incubated 
with 5:2 sFTOH, not with 5:3 acid [17].  This view was validated by the results of our 
previous study - PFHxA was detected while no 5:3 acid was produced during the 6:2 
FTOH degradation by P. butanovora with 1-butanol [31].  In this study, PFHxA was 
also not detected during the transformation of 5:3 acid by P. fluorescens DSM 8341. 
The possibility of  production of PFPeA from 5:2 sFTOH was proposed based 
on the following findings: (i) PFPeA was detected in all samples of strains employing 
both pathway I and II (except P. oleovorans with n-octane only) in this study and (ii) 
PFPeA was produced when 5:2 sFTOH was incubated in aerobic soils [17].  However, 
it is still not clear if PFPeA can be produced in both pathways because 5:3 acid was 
degraded into PFPeA via one-carbon removal pathways in Wang et al. [35] and by P. 
fluorescens DSM 8341 in this study. 
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The third possibility is that PFBA was converted from 5:2sFTOH via pathway I, 
based on the following observations: (i)P. oleovorans, M vaccae JOB5 and P. 
fluorescens DSM 8341 utilized both pathway I and II, and produced PFBA, and (ii) P. 
oleovorans and P. fluorescens DSM 8341 did not produce PFBA during 5:3 acid 
transformation (i.e. in pathway II).  P. butanovora did not produce PFBA either when 
taking pathway II only (1-butanol only) or when utilizing both pathways (in the presence 
of 1-butanol and lactate), indicating P. butanovora might not have ability to form PFBA.  
However, it is hard to conclude because M. vaccae JOB5 was not tested for 5:3 acid 
transformation and Wang et al. [35] monitored the formation of PFBA during 5:3 acid 
degradation in soils.  Transformation of longer-chain PFCAs to shorter ones (for 
example, from PFHxA to PFPeA or PFBA) was not observed with the strains tested in 
any condition (data not shown).Experiments using 5:2 sFTOH and these strains are 
needed to confirm this degradation pathway to PFBA. 
Since we did not observe any degradation of PFCAs to a shorter-chain PFCA or 
other transformation products with the strains used in this study under any conditions 
(data not shown), it was not considered that shorter PFCAs were originated from the 
longer PFCAs. 
Through x:3 acid pathway (pathway II), 6:2 FTUCA can be defluorinated to 5:3 
Uacid first, and then to 5:3 acid via a reduction step facilitated by the reducing power, 
NAD(P)H [17]. 5:3 acid can be further degraded via one-carbon removal pathways if the 
reversible dehydrogenation of 5:3 acid to 5:3 Uacid is not rate-limiting.  This view was 
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supported by the experimental results of this study using P. oleovorans, M. vaccae JOB5 
and P. fluorescens DSM 8341 under all the tested conditions, and P. butanovora with 
lactate.  If 5:3 acid was degraded similar to a fatty acid via β-oxidation, the expected 
metabolite would be PFHxA [35].  However, no PFHxA was detected during the 5:3 
acid transformation with P. fluorescens DSM 8341.  Instead, 5:3 Uacid, 5:2 Uacid, 4:3 
acid and PFPeA were detected, strongly supporting the occurrence of one-carbon 
removal pathways in P. fluorescens DSM 8341.  To employ β-oxidation for 5:3 acid 
transformation, 5:3 acid has to be activated by an acyl-Coenzyme A synthetase for 
further multiple defluorination and such activation was not observed in activated sludge 
[35].  Similarly, 5:3 acid also may not be activated by acyl-Coenzyme A synthetase in 
P. fluorescens DSM 8341, which instead utilized the one-carbon removal pathways to 
degrade 5:3 acid.   
In Figure 4.6, PFPeA was proposed to be converted from 5:2 sFTOH in pathway 
I (major route) [17] and from 4:2 sFTOH in pathway II (minor route via one-carbon 
removal pathways) [35].  To clarify the origin of PFPeA and other PFCAs, it can be 
hypothesized that certain enzymes can deploy the same degradation pathways by keep 
going through a cycle from polyfluorinated acid, polyfluorinated unsaturated acid, 
ketone, secondary alcohol, and then PFCAs with decreased carbon-chain lengths, 
respectively (Fig. 4.7).   
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Fig. 4.6. Proposed 6:2 FTOH degradation pathways by alkane-degrading bacteria and 
fluoroacetate-degrading bacteria.  The pathways taken commonly by all the bacteria are 
presented in red arrows.  Pathways taken by different strains are marked with the labels 
(A1-D2 from Table 4.1).  Compounds in boxes with dotted line are assumed 
metabolites, not analyzed. 
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In the proposed metabolic/degradation cycle, 6:2 FTOH is converted into 5:2 
sFTOH as described above.  It was proposed 5:2 sFTOH can produce two types of diols 
depending on the location of oxygen inserted: 5:2 diol Ⅰ (oxygen inserted at the 
terminal) and 5:2 diol Ⅱ (oxygen inserted in the middle of the compound) in cycle 1.  
From 5:2 diolⅠ, 5:1 aldehyde is produced with losing two hydrogens which is oxidized 
to an even-numbered PFCA, PFHxA.  5:2 diol Ⅱ is converted to 4:1 aldehyde with 
defluorination and loss of two hydrogens and 4:1 aldehyde is further transformed to an 
odd-numbered PFCA, PFPeA.  This supports the formation of PFHxA and PFPeA via 
PFCA pathway.  Assuming the same mechanism can be applied to 6:2 FTOH, it was 
proposed that PFHpA could be converted from 6:2 FTOH by producing a diol and then 
6:1 aldehyde, which could be converted to PFHpA. 
6:2 FTUCA can be converted to 5:3 Uacid, α-OH 5:3 acid, and then 5:2 
aldehyde via the one-carbon removal pathways.  5:2 aldehyde is oxidized to 5:2 acid 
which starts a new cycle and 4:2 sFTOH is transformed to PFPeA and even-numbered 
PFBA through the formation of corresponding diols and aldehydes.  This explains that 
PFPeA may also be produced via x:3 acid pathway.  We did not observe PFBA during 
5:3 acid degradation by P. oleovorans or P. fluorescens DSM 8341; however, Wang et al. 
[35] observed the formation of PFBA during 5:3 acid degradation by activated sludge.  
From 4:2 acid, formed from the ―Cycle 2‖ of Fig. 4.7, the third cycle starts to produce 
PFBA and possibly a shorter-chained PFCA as the same manner in ―Cycle 2‖. We did 
87 
 
not observe any degradation of PFCAs to shorter PFCAs or other products and thus 
PFCAs are the terminal metabolites during microbial degradation of 6:2 FTOH and other 
polyfluorinated chemicals such as 5:3 acid.  More studies are warranted, especially the 
degradation experiments using selected metabolites such as x:2 acid or x:2 sFTOH 
which might provide additional information to confirm the hypothesis of diol formation 
during 6:2 FTOH biodegradation that could lead to shorter-chain and odd numbered 
PFCAs.  A set of kinetic models was developed to describe 6:2 FTOH degradation and 
formation of its metabolites.  The detail of developed model was included in Table 
A4.1 in Appendix.  Results of 6:2 FTOH degradation was used to validate these models 
(Figure A4.1 in Appendix).  
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Fig. 4.7. Proposed enzymatic metabolic/degradation cycles to degrade 6:2 FTOH in bacteria.  Even-numbered (in purple) and odd-
numbered (in green) PFCAs are terminal products of each cycle.  The dashed arrows are possible unknown reactions. 
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5. DEVELOPMENT AND CHARACTERIZATION OF FTOH-DEGRADING 
MICROBIAL CONSORTIA 
 
5.1 Introduction 
 
FTOHs [F(CF2)nCH2CH2OH] are emerging environmental contaminants.  They 
are  used to manufacture a number of products due to its water- and oil- repelling 
properties [1].  6:2 and 8:2 FTOH showed estrogen potential on MCF-7 human breast 
cancer cells [26].  Also, 8:2 FTOH transformation products, especially 
perfluorooctanoic acid (PFOA), are known to cause many toxicological effects on lab 
animals [27-30].   
Many studies have demonstrated that FTOHs are biodegradable in mixed culture 
or pure strains alkane-degrading bacteria[17, 18, 24, 25, 31,32].  Our previous study 
has also shown that FTOHs were degraded by n-octane- and butane-degrading bacteria 
[31], suggesting that enhanced biodegradation of FTOH might be feasible through 
enriching these alkane-degrading cultures.  Enrichment an inoculum on FTOHs or 
structurally similar compounds (such as n-octane or 1-butanol) might increase the 
chance to obtain FTOH-degrading bacteria [33, 132].  Enhanced biodegradation of 
FTOHs can be accomplished by enrichment cultures containing FTOH-degrading 
consortia.  
90 
 
The objective of this study was to develop effective FTOH-degrading bacterial 
consortia and examine their ability to degrade FTOHs to environmental friendly end 
products.  It was hypothesized that enhanced FTOH degradation by the enrichment 
cultures are attributed to the possession of the enzymes actively involved in the 
degradation.  In our previous study, it was shown that alkane-degrading bacteria could 
defluorinate FTOHs efficiently [31].  Therefore, AlkB (alkane hydroxylase), a key 
enzyme for alkane degradation [107], was selected to detect alkane-degrading bacteria in 
the enrichment cultures to investigate the relation between the amount of degradative 
enzyme and FTOH degradation efficiency.  The detection of degradative enzymes is 
more efficient than 16S rRNA to capture the target microorganisms because the 
catabolic enzymes are evolved much faster [99].   
As different co-substrates used to develop FTOH-degrading consortia might 
lead to different patterns of microbial communities, the characteristics of the FTOH-
degrading consortia were also investigated using molecular tools.  Molecular methods 
based on DNAs directly from the bacteria in the environment provide more accurate and 
abundant information about the microorganisms than the traditional culture-dependent 
methods [99, 133].  Two molecular tools, real-time PCR for alk gene quantification[99] 
and real-time terminal restriction fragment length polymorphism (real-time-t-RFLP) 
assay for microbial community structure analysis [102], were used in this study.   
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5.2 Materials and methods 
 
5.2.1 Chemicals  
 
1H, 1H, 2H, 2H-heptadecafluoro-n-decanol (8:2 FTOH,CAS # 678-39-7, >96% 
pure), 1H, 1H, 2H, 2Hperfluorooctanol(6:2 FTOH, CAS # 647-42-7, 97% pure), and 1H, 
1H, 2H,2H-perfluorohexan-1-ol (4:2 FTOH, CAS # 2043-47-2) were purchased from 
TCIAmerica (manufactured in Tokyo, Japan), Alfa Aesar (Lancashire, UK), and Aldrich 
(Shinagawa-Ku, Japan), respectively.Hexane (95% pure) was obtained from Acros 
Organics(Morris Plains, NJ). 1-Butanol (99.4% pure) was purchasedfrom Fisher 
Scientific (Fair Lawn, NJ) and n-octane(97% pure) was from Acros Organics (Geel, 
Belgium).  Ethanol (95% pure) was from IBI scientific (Peosta, IA). 
 
5.2.2 Enrichment of FTOH-degrading microbial consortia 
 
FTOH-degrading microbial consortia were developed in 250 mL-glass bottles 
using activated sludge as inocula.  The sludge was collected from a WWTP receiving 
wastewater from a fire-fighting training field at Texas A&M University.  The activated 
sludge was first diluted in NMS medium to reach VSS ≒ 500 mg/L before use.  The 
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diluted activated sludge (100 mL) was then distributed into a 250- mL-autoclaved glass 
bottle and 1 % n-octane, 5 mM 1-butanol or no growth substrate was provided.  After 
the bottles were sealed with PTFE/SIL septa, 100 µL of 8:2 FTOH (40 g/L stock 
solution dissolved in ethanol) was added using a gas-tight syringe.  The enrichment 
cultures were maintained by transferring into the same fresh medium as described above, 
biweekly for about six months.  The enrichment cultures were named as FEO (enriched 
on 8:2 FTOH in ethanol and n-octane), FEB (8:2 FTOH in ethanol and 1-butanol) and 
FE (8:2 FTOH in ethanol). The ability of the enrichment cultures to degrade 8:2 FTOH 
was supported by the fluoride ion measurement as described previously [31]. 
 
5.2.3 FTOH degradation test 
 
The experiments for biodegradation of 4:2, 6:2 and 8:2 FTOHs by enrichment 
cultures were performed in a series of 22-mL glass vials containing cell suspension (1 
mL), one of FTOHs, and one of co-substrates (1-butanol or n-octane).  The enrichment 
cultures (1 mL) were transferred into vials containing fresh NMS medium (total volume 
= 5 mL).  One percent of n-octane, 5 mM of 1-butanol or no substrate was added and 
the vials were sealed with butyl rubber septa and aluminum caps before FTOH addition.  
Five micro-liters of 40 g/L 8:2 FTOH (dissolved in ethanol), 1 μL of 6:2 FTOH or 4:2 
FTOH (pure chemical, liquid) was injected into vials using a 25 μL-gas-tight syringe.  
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Killed controls, containing acid-killed cells (by adding 50 μL of concentrate sulfuric 
acid), each additional carbon source and FTOH, were also prepared to assess parent 
compound recovery during the degradation.  The vials were placed on a shaker at 150 
rpm in a 30 °C dark room.  At each of following sampling points (0, 2 and 4 days), two 
live samples and two killed controls were sacrificed for solvent extraction.  Two 
milliliters of hexane was added into the vials using a gas-tight syringe and the remaining 
FTOH was extracted overnight.  The hexane layer was withdrawn using a gas-tight 
syringe and transferred into a new capped GC amber vial (1.5 mL).  The samples were 
stored at – 20 °C until GC/MS analysis.  The aqueous layer in the old sample vials were 
preserved at 4 °C and later used for fluoride ion measurement.  GC analysis and 
fluoride measurement were conducted as described in our previous work [31].   
 
5.2.4 DNA extraction from enrichment cultures 
  
Twenty milliliters of cell suspensions were taken from each enrichment culture 
after about six months of transfer.  The cell suspensions were centrifuged (10,000 g for 
5min) and the pellets were used for DNA extraction.  The whole genomic DNAs of the 
enrichment cultures were extracted using the FAST DNA Spin Kit for Soil(MP, Solon, 
OH) and the DNAs were preserved at –20°C before used for alkB gene detection and 
real-time-t-RFLP analysis. 
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5.2.5 Real-time PCR for quantification of alkB gene and real-time-t-RFLP analysis for 
characterization of microbial community structure 
 
The extracted DNA was used as templates in real-time PCR assay for alkB gene 
quantification.  Amplification and detection were carried out in 96-well plates with 
SYBR-Greens PCR 2X Master Mix.  The alkB gene was amplified using the forward 
primer (5’-AAYACNGCNCAYGARCTNGGNCAYAA-3’) and reverse primer (5’-
AAYACNGCNCAYGARCTNGGNCAYAA-3’) [108-110].  Each reaction was run in 
a final volume of 25 μL with 1X final concentration of SYBR-Greens PCR 2X Master 
Mix, 4 mM of MgCl2, 5 pmol final concentration of each primer, 10 μg/μL of BSA, and 
2 μL of each DNA sample.  Amplifications were carried out using the following 
ramping profile: After 2 min at 50 °C, 15 min at 95 °C, followed by 1min at 94 °C, 1 
min at 55 °C, and 1 min at 72 °C for 39 cycles.  The iCycler iQ™ 5 Multicolor Real-
Time PCR Detection System (Bio-Rad, Hercules, CA) was used to quantify the amount 
of alkB gene in samples.  The plasmid containing alkB gene from P. oleovorans was 
constructed using TOPO TA cloning Kit (Invitrogen) and used for standard curves 
(range of 1.42 x 10
3
 to 1.42 x 10
10
 copies of alkB gene).  
Real-time-t-RFLP analysis was carried as described by Yu et al. [102].  Briefly, 
a region of 16S rRNA was amplified using fluorescence labeled forward primer 
16SHex1055f (5’-hexachlorofluorescein-ATGGCTGTCGTCAGCT-3’), reverse primer 
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16S1392r (ACGGGCGGTGTGTAC-3’),and TaqMan probe 16STaq1115f (5’-[6-
carboxyfluorescein]-CAACGAGCGCAACCC-[6-carboxytetramethylrhodamine]-3’).  
The PCR mixture was prepared and 16S rRNA was amplified as described in Yu 
et al.[102], except using a plasmid carrying E. coli 16S rRNA gene for preparing 
standard curves (2.28 x 10
1
 to 2.28 x 10
8 
copies of 16S rRNA gene).    The PCR 
products were separated on a 1.5% agarose gel in 1X Tris-acetate-EDTA buffer, and the 
DNA bands were excised for gel extraction (QIA quick Gel Extraction Kit, 
Maryland).The purified PCR products were then digested with restriction enzyme MspI 
and the digested PCR products were analyzed by AMI 3100 sequencer at the Gene 
Technology Lab, Texas A&M University.  
 
5.3 Results and discussion 
 
5.3.1 FTOH biodegradation by three enrichment cultures   
 
The mixed cultures enriched with n-octane, 1-butanolor no substrate along with 
8:2 FTOH (dissolved in ethanol) could degrade and defluorinate FTOHs (Fig. 5.1).FEO 
could degrade FTOHs most efficiently among the three consortia with 25 mol% removal 
of 8:2 FTOH applied at day 0, 59 mol% of 6:2 FTOH, and 68 mol% of 4:2 FTOH, 
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respectively.  This indicates that n-octane might be the most efficient co-substrate 
among tested carbon sources to induce the enzymes involved in FTOH degradation.  
Unlike 8:2 FTOH degradation test that 8:2 FTOH was supplied through 8:2 FTOH stock 
solution (i.e., containing some ethanol), during degradation tests for 6:2 and 4:2 FTOHs, 
they were amended as pure liquid compounds.  The amended 6:2 and 4:2 FTOH were 
degraded by FEO, suggesting that these two FTOHs were degraded by the enzymes that 
were already present in FEO.  These results support that a short-chained FTOH was 
degraded better than a long-chained FTOH by FEO (4:2 FTOH> 6:2 FTOH> 8:2 FTOH).  
Interestingly, the chain length of FTOH did not have significant effects on the extent of 
defluorination (4 % for 8:2 and 6:2 FTOHs, 3 % for 4:2 FTOHs).   
By enriching with 1-butanol, FEB was the second most effective FTOH-
degrading consortia with 20 mol% removal of 8:2 FTOH, 14 mol% of 6:2 FTOH and 68 
mol% of 4:2 FTOH.  The removal of 4:2 and 6:2 FTOH supports that the enzymes 
induced by 1-butanol is responsible for the degradation.  Different from those observed 
for FEO and FE, FEB defluorinated 3 % of 8:2 FTOH and 1 % of 6:2 FTOH, but 
showed very high defluorination with 4:2 FTOH (9 %).  In fact, this high defluorination 
of 4:2 FTOH was consistent with our previous study that P. butanovora, 1-butanol 
grown bacteria, defluorinated 4:2 FTOH in much higher degree than P. oleovorans, n-
octane grown bacteria did [31]. 
FE could degrade a slight amount of 8:2 FTOH (15 mol%) with 3 % of 
defluorination.  The poor degradation was also observed with 4:2 FTOH (8 mol%) and 
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6:2 FTOH (3 mol%) which applied as pure liquid compounds (not dissolved in ethanol).  
This result indicates that FE degrades FTOHs co-metabolically using enzymes induced 
by ethanol. 
Due to the structure similarity between n-alkanes and FTOHs, it was 
hypothesized that bacteria containing alkane-degrading enzymes might be responsible 
for FTOH degradation.  The copy number of alkB gene, a biomarker to detect alkane-
degrading bacteria, was quantified from each of FTOH-degrading consortium.  As 
shown in Figure 5.2a, FEO contained the highest number of alkB gene, followed by FEB 
and FE.  It seemed n-octane was a better co-substrate than 1-butanol or ethanol to 
induce alkane-degrading enzymes, and the more expression of AlkB brings better 
degradation of FTOHs.  
Figure 5.2b shows the portion of (detected) alkane-degrading bacteria in the 
total microorganisms in each FTOH-degrading consortium.  The amount of total 
microorganisms (i.e. total copy number of 16S rRNA gene) was the highest in FEO, 
followed by FEB and FE (data now shown).  Although FE contained the highest 
portion of alkane-degrading bacteria in total microbial community, least removal of 
FTOHs were observed for FE.  These results indicate that the enzymes expressed by 
alkane-degrading bacteria in FE may be not actively involved in FTOH degradation.  
While FEO had the highest number of alkB gene, a relatively lower population of 
alkane-degrading bacteria was observed in the community.  The better FTOH 
degradation observed in FEO could be explained by three hypotheses.  First, the FTOH 
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degradation is more dependent on the absolute number of the degradative bacteria.  
Second, FEO might contain many diverse alkane-degrading bacteria; however, they 
were not detected by the primers used in this study.  The primers used in this study 
could detect alkB genes from P. oleovorans grown on n-octane and P. butanovora 
grown on 1-butanol or hexane (data not shown).  However, it still remains unclear if the 
primers miss some alkane-degrading bacteria which are actively involved in FTOH 
degradation.  Third, different substrates induce different types of alkane 
monooxygenases with different affinity toward FTOHs.  For example, alkane 
monooxygenases expressed for medium-chain alkanes would not be effective for 
degrading short-chain or long-chain alkanes [110, 134,135].  It was possible that the n-
octane supplied to FEO simply promoted microorganisms with certain types of alkane 
monooxygenases suitable for degrading FTOHs.   
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Fig. 5.1. FTOH degradation (a) and defluorination (b) by each enrichment.  FEO: 
enrichment grown on 8:2 FTOH dissolved in ethanol and n-octane, FEB: enrichment 
grown on 8:2 FTOH dissolved in ethanol and 1-butanol, and FE: enrichment grown on 
8:2 FTOH dissolved in ethanol.  The degradation is presented in mol% of FTOH 
biodegraded of FTOH applied at day 0.The defluorination (b) was calculated like the 
following description. When 1 µM of FTOH (464.12 µg/L of 8:2 FTOH, 350 µg/L of 
6:2 FTOH, and 264 µg/L of 4:2 FTOH) is completely defluorinated 17 μM of fluoride 
for 8:2 FTOH, 13 μM for 6:2 FTOH, and 9 μM for 4:2 FTOH is released.  Therefore, 
based on the concentration of FTOH biodegraded, the defluorination can be expressed as 
{measured fluoride concentration (μM) / ideal fluoride concentration (μM) x 100}, 
where ideal fluoride concentration is {(17 μM of fluoride) / (concentration of 8:2 FTOH 
biodegraded, μM)} in a case of 8:2 FTOH.  
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Fig. 5.2. The copy number of alkB gene in each FTOH-degrading consortium (a) and 
ratio of alkane-degrading bacteria (detected) in total bacteria in alkB/16S rRNA (b).FEO: 
enrichment grown on 8:2 FTOH dissolved in ethanol and n-octane, FEB: enrichment 
grown on 8:2 FTOH dissolved in ethanol and 1-butanol, and FE: enrichment grown on 
8:2 FTOH dissolved in ethanol. 
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5.3.2 Microbial community structures of FTOH-degrading consortia 
 
On the third day of fresh transfer, when the enrichment cultures showed the 
highest growth (OD600nm ≒ 0.5 ~ 0.7), the samples were taken for real-time-t-RFLP 
analysis.  T-RFs shorter than 35 bp or longer than 350 bp in length, or those with less 
than 1 % of peak area were ignored.  All three enrichment cultures showed similar 
patterns of T-RF profiles (Fig. 5.3).  However, the quantity of microbial community 
was different depending on which additional carbon source was provided.  FEO 
consisted of microorganisms with 103, 104, 106, 115 and 327 bp of T-RF, and had the 
highest quantity of the communities.  FEB and FE had same T-RF patterns (99, 104, 
105, 327 and 350 bp), but FE had much less amount of microorganisms in the 
community.  When 16 rRNA sequences of P. oleovorans and P. butanovora (FTOH-
degraders [31]) were ideally digested with the same restriction enzyme, 108 bp and 106 
bp of T-RFs would be produced, respectively.  It indicates that all three enrichment 
cultures might have similar strains to P. oleovorans or P. butanovora in the community.   
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Fig. 5.3. T-RF profiles and 16S rRNA gene copy number in three enrichment cultures.  
The red arrow presents a possible T-RF for P. oleovorans or P. butanovora. 
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6. SUMMARY, CONCLUSIONS AND FUTURE STUDIES 
 
6.1 Summary and conclusions 
 
This is the first study reporting that pure alkane- and fluoroacetate-degrading 
bacteria could defluorinate FTOHs.  Three effective FTOH-degrading enrichment 
cultures were also developed with different co-substrates, and their microbial community 
structures were molecularly characterized.  The overall hypothesis of this work was that 
―Bacteria containing degradative enzymes for structurally similar substrates are 
responsible for FTOH biotransformation in the natural environment‖.  The hypothesis 
was supported by the results listed below. 
 
1) Medium-chain alkane-degrading bacteria, P. oleovorans and P. butanovora 
could defluorinate 4:2, 6:2 and 8:2 FTOHs, with a higher degree of 
defluorination for 4:2 FTOH.  Based on the transformation products detected, 
two possible pathways were proposed for 6:2 and 8:2 FTOH degradation by P. 
oleovorans and P. butanovora.  The PFCA pathway (pathway I) led to the 
production of x:2 ketone, x:2 sFTOH, PFCAs (PFHxA for 6:2 FTOH and PFOA 
for 8:2 FTOH).  The x:3 acid pathway (pathway II) resulted in the formation of 
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x:3 polyfluorinated acid (x:3 acid) and relatively minor shorter-chain PFCAs 
(PFBA for 6:2 FTOH and PFHxA for 8:2 FTOH).  P. oleovorans transformed 
6:2 and 8:2 FTOH via both pathways I and II, while P. butanovora only utilized 
pathway I.  The formation of shorter-chain PFCAs suggests that a complete 
enzyme system does exist in pure bacterial strain to remove multiple –CF2- 
groups from FTOHs.  
2) Gram-positive alkane-degrading bacteria, M. vaccae JOB5, and fluoroacetate-
degrading bacteria, P. fluorescens DSM 8341, also could transform 6:2 FTOH 
into at least nine metabolites via both PFCAs and x:3 acid pathways (pathways I 
and II).  These two strains degraded 6:2 FTOH much slower than P. 
oleovorans or P. butanovora, but produced newly detected odd-numbered short-
chain PFCAs such as PFPeA or PFHpA.  This result shows the possibility of 
more diverse bacteria in the environment which can transform 6:2 FTOH 
possibly in more various mechanisms.  
3) The presence of co-substrates affected on the degradation of 6:2 FTOH by the 
strains tested.  The presence of DCPK (alkane hydroxylase enhancer) caused 
much faster transformation of 6:2 FTOH in P. oleovorans and the formation of 
odd-numbered PFCAs (PFPeA and PFHpA).  In the presence of lactate (an 
odd-numbered carbon and reductant), P. butanovora was able to utilize not only 
the PFCA pathway but also the x:3 acid pathway to transform 6:2 FTOH and 
produce odd-numbered PFCAs (PFPeA and PFHpA).  
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4) No observation for PFCAs (PFOA, PFHxA and PFBA) degradation by any 
strain tested.  However, P. fluorescens DSM 8341 slightly transformed 5:3 acid 
into 5:3 Uacid, α-OH 5:3 acid, 5:2 acid, 5:2 Uacid and then 4:3 acid and PFPeA 
via one-carbon removal pathways.  This result indicates that complete 
mineralization of 6:2 FTOH might be possible by synergy of diverse enzymes 
expressed by various FTOH-degrading bacteria in mixed cultures.   
5) Based on the transformation products in PFCA pathway, x:3 acid pathway 
and one-carbon removal pathway, a possible generalized cycle in 6:2 FTOH was 
proposed.  In this cycle, it was proposed that x:2 perfluorinated acid might be 
converted to x:2 unsaturated perfluorinated acid, x:2 ketone, and then x:2 
sFTOH.  x:2 sFTOH might be then transformed to corresponding short-chain 
PFCA, and (x-1):2 perfluorinated acid which goes through the cycle repeatedly.  
6) FTOH-degrading consortia were developed by enriching on n-octane (FEO), 
1-butanol (FEB), or no substrate (FE) along with 8:2 FTOH dissolved in ethanol.  
FTOHs were degraded co-metabolically by the three consortia and n-octane 
seemed to enhance the degradation greater than other co-substrates.  The 
amount of alkB gene (a biomarker for alkane-degrading bacteria) was in order of 
FEO > FEB > FE and the higher gene copy number of alkB led to the better 
degradation of FTOHs.  Real-time-t-RFLP showed that the three enrichment 
cultures had similar patterns of T-RF profiles, but different quantities of 
microbial community depending on the carbon source (n-octane > 1-butanol 
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>ethanol).  All of the three FTOH-degrading consortia contained microbial 
groups having similar T-RF to P. oleovorans and P. butanovora, FTOH-
degraders. 
 
6.2 Future studies 
 
This study provided information that several bacteria are possibly responsible 
for FTOH degradation in the environment.  The microbial community of FTOH-
degrading consortia were also characterized and discussed.  However, the results of this 
study brought many questions and drew attentions to several future studies.  Below are 
suggestions for future studies that might help answer the unanswered questions in this 
study. 
 
1) The specific enzymes responsible for each step for FTOH degradation were 
not investigated in this study and remain unknown.  Purification and 
identification of enzymes expressed during the degradation will provide better 
understanding of FTOH biotransformation.   
2) Even though the biotransformation pathways for FTOHs were proposed, 
some parts such as the origin of PFPeA are still unclear.  More degradation 
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studies of selected metabolites such as x:2 ketone, x:2 sFTOH or (x-1):2 acid are 
necessary to elucidate FTOH pathways to deeper levels. 
3) Based on the results of this study, it might be possible to construct artificial 
microbial community or enrichment cultures for enhanced FTOH degradation.  
For example, P. oleovorans transforms FTOHs very fast (especially, in the 
presence of DCPK or formate), but cannot degrade further than 5:3 Uacid.  P. 
fluorescens DSM 8341 is relatively slow in FTOH degradation, but able to 
transform 5:3 acid to more down-streamed metabolites.  Therefore, the mixture 
of these two strains can used to investigate the possibility of FTOHs 
mineralization.  The substrate competition and toxicity of each substrate need 
to be studied first before constructing the combined cultures.  
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Table A1.1. Structures of perfluorinated compounds 
Compound Structure 
Fluorotelomer alcohols (FTOHs) 
4:2 FTOH 
 
 
 
 
 
6:2 FTOH 
 
 
 
 
 
8:2 FTOH 
 
 
 
 
 
 
Fluorotelomer (unsaturated) acid 
6:2 FTCA 
 
 
 
 
 
 
 
8:2 FTCA 
 
 
 
 
 
 
 
6:2 FTUCA 
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8:2 FTUCA 
 
 
 
 
 
Polyfluorinated acid 
5:3 acid 
 
 
 
 
 
 
5:3 U acid 
 
 
 
 
 
 
7:3 acid 
 
 
 
 
 
 
7:3 U acid 
 
 
 
 
 
 
ketone 
5:2 ketone 
 
 
 
 
 
7:2 ketone 
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Secondary fluorotelomer alcohols 
5:2 sFTOH 
 
 
 
 
 
7:2 sFTOH 
 
 
 
 
 
 
Perfluorinated carboxylic acids (PFCAs) 
Perfluorononanoic acid (PFNA) 
 
 
 
 
 
 
Perfluorooctanoic acid (PFOA) 
 
 
 
 
 
 
Perfluorohexanoic acid (PFHxA) 
 
 
 
 
 
 
Perfluoropentanoic acid (PFPeA) 
 
 
 
 
 
 
Perfluorobutanoic acid (PFBA) 
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Other perfluorinated compounds 
5:3 u amid 
 
 
 
 
 
 
7:3 u amid 
 
 
 
 
 
 
2H PFOA 
 
 
 
 
 
 
perfluoro-1-octane sulfonate (PFOS) 
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Fig. A3.1. GC/ECD chromatography for 4:2 FTOH transformation by P.oleovorans in 
the absence of n-octane. 
 
 
 
 
 
 
P. oleovorans + 4:2 FTOH: 
0h 
4:2 
FTOH 
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Not detected 
4:2 FTOH  
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P. oleovorans + 4:2 FTOH: 
48h 
Peak 2 
Peak 1 
Peak 1 
Peak 2 
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Fig. A3.2. GC/ECD chromatography for 4:2 FTOH transformation by P. butanovora in 
the absence of 1-butanol (A) and in the presence of 1-butanol (B). 
 
 
P
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Fig. A3.2. Continued 
 
 
 
B: In the presence of 1-butanol 
4:2 FTOH P. butanovora + 4:2 FTOH + 
1-butanol: 0h 
Peak 2 4:2 FTOH 
P. butanovora + 4:2 FTOH + 
1-butanol: 24h 
Peak 1 
P. butanovora + 4:2 FTOH + 
1-butanol: 72h 
Peak 5 
Peak 2 4:2 FTOH 
Peak 1 
Peak 5 
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Fig. A3.3. 6:2 FTOH transformation by P. oleovorans (A), and detection of unidentified 
metabolites using GC-ECD (B): diamond-control, square-killed control, triangle-FTOH 
only, circle- FTOH with additional carbon source (n-octane).  As the parent compound 
disappears, two new peaks (peak 1 and 2) were showed up and increased over time. 
[
B] P. oleovorans + 6:2 FTOH: 
0h 
P. oleovorans + 6:2 FTOH: 
9h 
P. oleovorans + 6:2 FTOH: 
24h 
6:2 FTOH 
Peak 1 
6:2 FTOH 
Peak 2 
Peak 1 
6:2 FTOH Peak 2 
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Fig.A3.4. 8:2 FTOH transformation by P. oleovorans (A), and detection of unidentified 
metabolites using GC-ECD (B): diamond-control, square-killed control, triangle-FTOH 
only, circle- FTOH with additional carbon source (n-octane).  As the parent compound 
disappears, two new peaks (peak 1 and 2) were showed up and increased over time. 
 
[
B] 
P. oleovorans + 8:2 FTOH : 
24h 
Peak 1 
Peak 2 
8:2 FTOH 
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Table A3.1.  The amounts of 4:2 FTOH removed and fluoride released in cell suspension of P. oleovorans and P. 
butanovora dosed with 4:2 FTOH.  The 4:2 FTOH starting concentration is 318 mg/L in cell culture (1590 μg or 6.0 μmol 
4:2 FTOH was added to the 5 mL cell suspension).  The samples were extracted for 4:2 FTOH and fluoride analysis 48 h for 
P. oleovorans and 96 h for P. butanovora after the initiation of 4:2 FTOH biotransformation experiments.  The values were 
average from duplicate samples. 
Bacterial 
Strains 
4:2 FTOH applied 
(μM) 
 
 
4:2 FTOH biodegraded
a
 
(μM) 
 
 
Fluoride measured 
(μM) 
 
 
Defluorination efficiency 
(% maximum*) 
 
 P. oleovorans 
+ n-octane   No n-octane + n-octane     No n-octane + n-octane    No n-octane + n-octane   No n-octane 
1205      1205 
 
751         894 
 
400        826 
 
5.9
§            
10.3 
 
P. butanovora 
+ 1-butanol   No 1-butanol + 1-butanol   No 1-butanol + 1-butanol  No 1-butanol + 1-butanol  No 1-butanol 
1205      1205 405         467 1174       1574 32        37.3 
*: When 1 µM of 4:2 FTOH (264 µg/L) is completely defluorinated, 9 uM of fluoride is released.  Therefore, the complete 
defluorination of 4:2 FTOH biodegraded (a) will result in (9 × a) μM of fluoride release (production) ideally. 
§: {400 μM of measured fluoride /(9 μM of fluoride × 751 μM of 4:2 FTOH biodegraded)} × 100 % = 5.9 %
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Table A3.2.Instrumental method for analysis of 6:2 FTOH and transformation products 
by LC/MS/MS. 
Instrument: Waters Model 2795 High Performance Liquid Chromatograph with a Waters Quattro 
Micro Mass Spectrometer equipped with an electrospray source. The mass spectrometer 
was operated in the negative ion multiple reaction-monitoring mode. 
Analytical Column: Agilent Zorbax RX-C8 (150 mm x 2.1 mm, 5 μm particle size, pore size 80 Å, not end-
capped, carbon loading 5.5%) 
Column Temperature: 30°C 
Mobile Phases: A: 0.15% acetic acid in nanopure water 
B: 0.15% acetic acid in acetonitrile 
Gradient Profile: Time (min) Percentage A Flow Rate (mL/min) 
0.0 90 0.400 
1.0 90 0.400 
1.1 45 0.400 
2.0 45 0.400 
7.5 20 0.400 
7.6 90 0.400 
8.0 90 0.400 
 
Injection Volume: 10 - 20 μL 
Monitored Ion 
Transitions: 
Analytes (LOD*) Ion Transitions Cone Voltage, V Collision Energy 
PFBA (0.50) 213 > 169 14 8 
PFPeA (0.50) 263 > 219 14 8 
PFHxA (0.50) 313 > 269 14 8 
PFHpA (0.20) 363 > 319 16 10 
[M+2] PFHxA 315 > 270 14 8 
5:2 ketone (10) 389 > 311 8 10 
6:2 FTCA (2.1) 377 > 293 16 16 
6-2 FTUCA (1.0) 357 > 293 16 14 
4:3 acid (3.0) 291 > 187 18 13 
5:3 u acid (3.0) 339 > 255 16 14 
5:3 acid (1.9) 341 > 237 18 13 
5:2 sFTOH (11) 373 > 59 12 8 
6-2 FTOH (7.0) 423 > 59 12 8 
[M+5] 6-2 FTOH 428 > 59 12 8 
 
* LOD: Limit of detection defined as lowest calibration standard in µg L-1. 
LC/MS/MS Analog 
Parameters: 
Capillary (kV) = 3.50 Q 1: unit resolution 
Extractor (V) = 0 Ion Energy 1 = 0.6 
RF Lens (V) = 0 Entrance = -1 
Source Temperature (°C) = 120 Exit = 0 
Desolvation Temperature (°C) = 250 Q 2: unit resolution 
Cone Gas Flow (L/Hr) = 50 Ion Energy 2 = 0.6 
Desolvation Gas Flow (L/Hr) = 500 Multiplier (V) = 700 
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Table A3.3.Instrumental method for analysis of 8:2 FTOH and metabolites 
(transformation products) by LC/MS/MS. 
Instrument: Waters Model 2795 High Performance Liquid Chromatograph with a Waters Quattro 
Micro Mass Spectrometer equipped with an electrospray source. The mass spectrometer 
was operated in the negative ion multiple reaction-monitoring mode. 
Analytical Column: Agilent Zorbax RX-C8 (150 mm x 2.1 mm, 5 μm particle size, pore size 80 Å, not end-
capped, carbon loading 5.5%) 
Column Temperature: 30°C 
Mobile Phases: A: 0.15% acetic acid in nanopure water 
B: 0.15% acetic acid in acetonitrile 
Gradient Profile: Time (min) Percentage A Flow Rate (mL/min) 
0.0 90 0.400 
1.0 90 0.400 
1.1 45 0.400 
2.0 45 0.400 
7.5 20 0.400 
8.0 10 0.400 
8.5 10 0.400 
9.0 90 0.400 
10.0 90 0.400 
 
Injection Volume: 10 - 20 μL 
Monitored Ion 
Transitions: 
Analytes (LOD*) Ion Transitions Cone Voltage, V Collision Energy 
PFHxA (0.50) 313 > 269 14 8 
PFHpA (0.20) 363 > 319 16 10 
PFOA (0.5) 413 > 369 16 10 
[M+2] PFOA 415 > 370 20 10 
PFNA (0.5) 463 > 419 15 10 
7:2 ketone (10) 489 > 411 8 10 
8:2 FTCA (2.1) 477 > 393 16 16 
8-2 FTUCA (1.0) 457 > 393 16 14 
7:3 u acid (3.0) 439 > 369 16 14 
7:3 acid (3.0) 441 > 337 16 16 
7:2 sFTOH (10) 473 > 59 12 20 
8-2 FTOH (10) 523 > 59 12 20 
[M+5] 8-2 FTOH 528 > 59 12 20 
* LOD: Limit of detection defined as lowest calibration standard in µg L-1. 
LC/MS/MS Analog 
Parameters: 
Capillary (kV) = 3.50 Q 1: unit resolution 
Extractor (V) = 0 Ion Energy 1 = 0.6 
RF Lens (V) = 0 Entrance = -1 
Source Temperature (°C) = 120 Exit = 0 
Desolvation Temperature (°C) = 250 Q 2: unit resolution 
Cone Gas Flow (L/Hr) = 50 Ion Energy 2 = 0.6 
Desolvation Gas Flow (L/Hr) = 500 Multiplier (V) = 700 
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Table A3.4. FTOHs remaining and transformation products formed per initially applied 
FTOHs on 28 day (%) 
 P. oleovorans P. butanovora  P. oleovorans P. butanovora 
6:2 FTOH 
remaining a 
0.85 ND 
8:2 FTOH 
remaining a 
2.51 ND 
Transformation products formed b Transformation products formed b 
6:2 FTCA 0.23 33.4 8:2 FTCA 1.21 0.28 
6:2 
FTUCA 
7.26 43.5 8:2 FTUCA 4.3 19.58 
5:2 ketone 10.3 31.8 7:2 ketone 20.2 10.4 
5:2 sFTOH 24.1 1.21 7:2 sFTOH 9.63 17.9 
PFHxA 2.72 2.87 PFOA 2.68 7.3 
5:3 Uacid 9.06 ND PFHxA 0.62 0.61 
5:3 acid 4.71 ND 7:3 Uacid 2.9  
PFBA 0.44 ND 7:3 acid 1.78  
a) [(6:2 FTOH remaining on day 28) / (6:2 FTOH initially applied on day 0)] * 100 
b) [(transformation products formed on day 28) / (6:2 FTOH initially applied on 
day 0)] * 100 
- ND: not detected 
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Table A4.1. Kinetic models of 6:2 FTOH degradation and metabolites formation 
Major metabolites in 6:2 FTOH degradation 
 
 
 
Kinetic models 
 
d[A]
dt
= −k1 × [A] 
 
d[B]
dt
= k1 A −  k2[B] 
 
d[C]
dt
= k2 B −  k3 C −  k4[C] 
 
d[D]
dt
= k3[C] 
 
d[E]
dt
= k4[C] 
 
Where, A = 6:2 FTOH, B = 6:2 FTCA, C = 6:2 FTUCA, D = 5:2 ketone, E = 5:3 acid 
 
Calculation of k values and concentrations 
Step 1 
 
k1 and [A] 
 
(1) Integrate dA/dt  
 
k1=  
ln  A 0−ln⁡[A]
t−t0
 
 
(2) Find k1 by using the concentrations for A from the real data 
(3) [A] = [A]0 * exp(-k1*t) 
Using k1 and [A]0, calculate the concentration of [A] at t 
 
 
6:2 FTOH 6:2 FTCA 
k1 
6:2 FTUCA 
k2 
5:2 ketone 
k3 
5:3 acid k4 
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Step 2 
 
k2 and [B] 
 
(1) Integrate dB/dt 
 
 B =   B 0 −  
k1 ×  A 0
k2 − k1
 × exp −𝑘2 × 𝑡  
 
+ 
k1 ×  A 0
k2 − k1
 × exp −k1 × t  
 
(2) Assume [B]0 = 0; Use k1 and [A]0 from the above 
(3) On an Excel sheet, find k2 which produces the best fitting 
concentration of [B] at each time point, comparing to [B] from 
the real data 
 
Step 3 
 
k3, k4 and [C] 
 
(1) Integrate dC/dt 
 
 C =   C 0 − P − Q × exp − k3 + k4 × t   
 
+ P × exp −k2 × t +  Q × exp⁡(−k1 × t) 
 
Where,  
 
P =  
k2 ( B 0 −
k1×  A 0
k2−k1
)
 k3 + k4 − k2
 
 
Q =  
k2 ×  
k1×  A 0
k2−k1
 k3 + k4 − k1
 
 
(2) Assume [C]0 = 0; Use k1, k2, [A]0 and [B]0 from step 2 
(3) On an Excel sheet, find k3 and k4 which provide the best fitting 
concentration of [C], comparing to [C] from the real data 
Step 4 
 
[D] and [E] 
 
(1) Integrate dD/dt and dE/dt 
 
D = D0 + k3 * [C] * t 
 
E = E0 + k4 * [C] * t 
 
(2) Calculate the concentration of [C] and [D] 
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Fig. A4.1   Validation of the kinetic models.  (a) 6:2 FTOH and the major metabolites 
by the models and experiment for P. butanovora in the presence of 1-butanol, (b) 6:2 
FTOH by the models and experiment for different strains in various conditions 
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